multiple endocrine neoplasia

human disease

DBpedia resource is: http://dbpedia.org/resource/Multiple_endocrine_neoplasia

Abstract is: Multiple endocrine neoplasia (abbreviated MEN) is a condition which encompasses several distinct syndromes featuring tumors of endocrine glands, each with its own characteristic pattern. In some cases, the tumors are malignant, in others, benign. Benign or malignant tumors of nonendocrine tissues occur as components of some of these tumor syndromes. MEN syndromes are inherited as autosomal dominant disorders.

Wikimedia Commons category is Multiple endocrine neoplasia

multiple endocrine neoplasia is …
instance of (P31):
class of diseaseQ112193867

sublass of (P279):
endocrine gland neoplasmQ3542030
multiple polyglandular tumorQ55785235

External links are
P8313Den Store Danske IDmultipel_endokrin_neoplasi
P699Disease Ontology IDDOID:3125
P1417Encyclopædia Britannica Online IDscience/multiple-endocrine-neoplasia
P2888exact matchhttp://purl.obolibrary.org/obo/DOID_3125
http://www.orpha.net/ORDO/Orphanet_276161
P646Freebase ID/m/01pghs
P7464Genetics Home Reference Conditions IDmultiple-endocrine-neoplasia
P494ICD-10 IDD44.8
P4229ICD-10-CMD44.8
P493ICD-9 ID258.0
P1692ICD-9-CM258.0
P563ICD-O8360/1
P3827JSTOR topic ID (archived)multiple-endocrine-neoplasia
P665KEGG IDH00247
P604MedlinePlus ID000399
000399
000398
000398
P486MeSH descriptor IDD009377
P672MeSH tree codeC04.588.322.400
C04.651.600
C04.700.630
C16.320.700.630
C19.344.400
P6366Microsoft Academic ID2780103800
P5270Mondo IDMONDO_0017169
P1748NCI Thesaurus IDC6432
P10283OpenAlex IDC2780103800
P1550Orphanet ID276161
P4233PatientsLikeMe condition IDmultiple-endocrine-neoplasia
P2892UMLS CUIC0027662

P1995health specialtyendocrinologyQ162606
P5008on focus list of Wikimedia projectWikiProject MedicineQ4099686

Reverse relations

medical condition (P1050)
Q6607718768Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
Q64665307A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
Q63011572Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
Q63813116Familial Investigations of Childhood Cancer Predisposition
Q65377039High Dose Somatostatin Analogues in Neuroendocrine Tumors
Q66061188Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)
Q64139816Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
Q64150993Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Q113919591Natural History Study of Parathyroid Disorders
Q65397269Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment
Q61920721Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer
Q61980339Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes
Q64634650Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Q64150991Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2
Q64170974Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
Q64189438Studies of Inherited Diseases of Metabolism
Q64788912Study and Follow-up of Multiple Endocrine Neoplasia Type 1
Q66065870Study and Monitoring of Multiple Endocrine Neoplasia Type 1
Q63321443Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
Q66391372The Master Registry of Oncology Outcomes Associated With Testing and Treatment
Q65544619Treatment of Zollinger-Ellison Syndrome With Prevacid
Q64836512Type 1 Multiple Endocrine Neoplasia Cohort Study
Q64694561Vancomycin Associated Red Man Syndrome (RMS)
Q61978915Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
Q66072649Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
Q66398124Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
Q64219813Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

subclass of (P279)
Q5044023Carney's triad
Q3347154multiple endocrine neoplasia type 1
Q56014243multiple endocrine neoplasia type 2
Q604075multiple endocrine neoplasia type 2A
Q624748multiple endocrine neoplasia type 2B
Q26492830multiple endocrine neoplasia type 4

main subject (P921)
Q39154238(35) Multiple endocrine adenomatosis (Type i) with cutaneous leiomyomata and cysts of Moll
Q50093709...About multiple endocrine neoplasia type 1.
Q6002168210 Multiple endocrine neoplasia
Q7442984510 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods
Q7480557311q13 allelic loss in pituitary tumors in patients with multiple endocrine neoplasia syndrome type 1
Q93496878: Multiple endocrine neoplasia associated with von Recklinghausen's disease
Q71859445A 1.5-megabase physical map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13
Q48048567A 2.8-Mb clone contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13.
Q64916924A 37-year-old married woman with 3-month history of galactorrhoea and irregular menstrual cycle. Diagnosis: multiple endocrine neoplasia type 1 (MEN 1), also known as Wermer's syndrome.
Q73911375A 5178-9g--> A splice donor site mutation in intron 4 of the MEN1 gene causing multiple endocrine neoplasia type 1
Q45071162A Case Report of Recurrent Severe Peripartum Cardiomyopathy Complicated by Factor V Leiden and Multiple Endocrine Neoplasia Type 1: A Management Conundrum
Q57500090A Case of Multiple Endocrine Neoplasia Type 1 with Mutation in MENIN Gene
Q66073188A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Q34589821A Drosophila model of multiple endocrine neoplasia type 2.
Q79110269A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men
Q72467878A Kindred with 5 Cases of Multiple Endocrine Adenomatosis Type I
Q40655217A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.
Q50436253A Novel Missense Mutation of the MEN1 Gene in a Patient with Multiple Endocrine Neoplasia Type 1 with Glucagonoma and Obesity.
Q91822733A Peculiar Phenotype Hindering Early Diagnosis: Multiple Endocrine Neoplasia 2B Syndrome
Q64654941A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers
Q38970737A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation
Q57577941A Rare Extracellular D631Y Germl ine Mutation of the RET Proto-Oncogene in Two Korean Families with Multiple Endocrine Neoplasia 2A
Q65385409A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Q42485460A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1.
Q84759852A case of Takotsubo's cardiomyopathy and multiple endocrine neoplasia 2A syndrome
Q39265047A case of Zollinger-Ellison syndrome associated with multiple endocrine adenomatosis (Type I)--special reference to treatment of Zollinger-Ellison syndrome with cimetidine (author's transl)
Q47956847A case of Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1 with urolithiasis as the initial presentation
Q77401664A case of Zollinger-Ellison syndrome produced by gastrinoma in the duodenum accompanied with multiple endocrine neoplasia type 1
Q64990394A case of acute myocardial infarction with multiple endocrine adenomatosis and two primary carcinomas.
Q39239808A case of chronic calcifying pancreatitis associated with familial primary hyperparathyroidism suggesting multiple endocrine adenomatosis (type I) (author's transl)
Q49980308A case of human ocular dirofilariasis in a patient with multiple endocrine neoplasia in Northwest Spain
Q72557488A case of multiple endocrine adenomatosis (Type 1) with nesidioblastosis, terminating with an exocrine pancreatic carcinoma
Q69893883A case of multiple endocrine adenomatosis type 1
Q72594664A case of multiple endocrine adenomatosis with atypical mesenteric localization of 2 gastrinomas
Q36715084A case of multiple endocrine adenomatosis with primary amenorrhoea
Q69370673A case of multiple endocrine neoplasia (MEN) type 1; the immunohistochemical and ultrastructural studies of its tumors and the analysis of hormones in tumor extracts
Q72578954A case of multiple endocrine neoplasia (MEN), type 2A. Immunohistochemical and ultrastructural study of medullary carcinoma of the thyroid
Q37041040A case of multiple endocrine neoplasia type 1 combined with papillary thyroid carcinoma
Q33879692A case of multiple endocrine neoplasia type 1 with primary liver gastrinoma
Q46595405A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins
Q42468673A case of multiple endocrine neoplasia type II b: endocrinological evaluation and family screening
Q67521432A case of multiple endocrine neoplasia: hyperparathyroidism, insulinoma, GRF-oma, hypercalcitoninaemia and intractable peptic ulceration
Q33760432A case of multiple gastric carcinoids associated with multiple endocrine neoplasia type 1 without hypergastrinemia
Q36300041A case of type 1 multiple endocrine neoplasia with esophageal stricture successfully treated with endoscopic balloon dilation and local steroid injection combined with surgical resection of gastrinomas
Q50310730A de novo 0.57 Mb microdeletion in chromosome 11q13.1 in a patient with speech problems, autistic traits, dysmorphic features and multiple endocrine neoplasia type 1.
Q40625457A dento-cranio-facial study of the multiple endocrine neoplasia (MEN) type 3 syndrome
Q37023603A differential diagnosis of inherited endocrine tumors and their tumor counterparts
Q72670784A family pedigree exhibiting features of both multiple endocrine neoplasia type 1 and McCune-Albright syndromes
Q72550874A family with Multiple Endocrine Neoplasia Type 1
Q72543740A family with a 16qh+ chromosome and multiple endocrine neoplasia type II
Q39258403A family with multiple endocrine adenomatosis (MEA Type I) and some additional peculiarities alpha-1-antitrypsin deficiency (twice), polyp of small intestine with heterotopic gastric mucosa (once), medullary thyroid carcinoma (once) (author's transl)
Q39130721A family with multiple endocrine adenomatosis type 1 associated with hyperparathyroidism
Q69875733A family with multiple endocrine neoplasia type I presenting prolactinoma, Zollinger-Ellison syndrome and hyperparathyroidism
Q89307474A follow-up study of patients with MEN syndromes - five case reports
Q81863271A germline mutation in a Thai family with familial multiple endocrine neoplasia type 1
Q43669163A germline mutation, 1001delC, of the multiple endocrine neoplasia type 1 (MEN 1) gene in a Japanese family.
Q45020406A kindred of multiple endocrine neoplasia type 2B
Q73047790A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13
Q49833911A laparoscopic revelation: incidental nodule in a patient with bilateral phaeochromocytoma in multiple endocrine neoplasia Type 2A.
Q99210231A large Turkish pedigree with multiple endocrine neoplasia type 1 syndrome carrying a rare mutation: c.1680_1683 del TGAG
Q86070383A large functioning parathyroid cyst in a patient with multiple endocrine neoplasia type 1
Q54960820A large germline deletion of the MEN1 gene in a family with multiple endocrine neoplasia type 1.
Q73785082A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation
Q69857105A linkage study of multiple endocrine neoplasia type IIa
Q41612073A long-sought needle in the haystack: the multiple endocrine neoplasia type 1 gene
Q73608160A malignant gastrointestinal stromal tumour in a patient with multiple endocrine neoplasia type 1
Q42523470A meal stimulation test in the diagnosis of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
Q72709815A metastatic neuroendocrine anaplastic small cell tumor in a patient with multiple endocrine neoplasia type 1 syndrome. Assessment of disease status and response to doxorubicin, cyclophosphamide, etoposide chemotherapy through scintigraphic imaging
Q40481638A model for GFR alpha 4 function and a potential modifying role in multiple endocrine neoplasia 2.
Q28592210A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
Q41837359A new association - multiple endocrine neoplasia type 1 and malignant peripheral nerve sheath tumor
Q82421607A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma
Q77405103A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1
Q39119876A new pattern of multiple endocrine adenomatosis: chemodectoma, bronchial carcinoid, GH-producing pituitary adenoma, and hyperplasia of the parathyroid glands, and antral and duodenal gastrin cells
Q42517629A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.
Q53475192A non-acromegalic case of multiple endocrine neoplasia type 1 accompanied by a growth hormone-releasing hormone-producing pancreatic tumor.
Q60021415A novel MEN1 intronic mutation associated with multiple endocrine neoplasia type 1
Q37628662A novel MEN1 mutation in a Japanese adolescent with multiple endocrine neoplasia type 1.
Q98514053A novel MEN1 pathogenic variant in an Italian patient with multiple endocrine neoplasia type 1
Q92226343A novel case of myxoid variant of adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1
Q52611857A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
Q68164087A novel endothelial cell growth factor circulates in familial multiple endocrine neoplasia type 1
Q77659853A novel germline mutation in exon 5 of the multiple endocrine neoplasia type 1 gene
Q78165760A novel germline mutation of multiple endocrine neoplasia type 1 (MEN1) gene in a Japanese MEN1 patient and her daughter
Q54495167A novel germline mutation of the MEN1 gene caused multiple endocrine neoplasia type 1 in a Chinese young man and 1 year follow-up.
Q73834460A novel germline mutation of the MEN1 gene, L259del, in a patient with sporadic multiple endocrine neoplasia type 1 (MEN1)
Q81748663A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1
Q40645055A novel in-frame deletion in MEN1 (p.Ala416del) causes familial multiple endocrine neoplasia type 1 with an aggressive phenotype and unexpected inheritance pattern
Q83951661A novel intronic mutation and a missense mutation of MEN1 identified in two Chinese families with multiple endocrine neoplasia type 1
Q83851522A novel menin gene deletional mutation in a little series of Italian patients affected by apparently sporadic multiple endocrine neoplasia type 1 syndrome
Q37860028A novel missense mutation in the MEN1 gene in a patient with multiple endocrine neoplasia type 1.
Q44700044A novel missense mutation of the MEN1 gene in a multiple endocrine neoplasia type 1 patient associated with carcinoid syndrome.
Q84741073A novel mutation of the MEN1 gene in a Chinese kindred with multiple endocrine neoplasia type 1
Q100384642A novel mutation of the MEN1 gene in a patient with multiple endocrine neoplasia type 1 and recurrent fibromyxoid sarcoma - a case report
Q78054901A novel splicing mutation (894-9 G --> A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1
Q52647064A patient with an apparently sporadic pheochromocytoma with a rearranged during transfection codon 635 variant: a mild form of multiple endocrine neoplasia type 2?
Q74438513A patient with multiple endocrine neoplasia type 1 with a novel MEN1 gene mutation (237delC)
Q42149768A pituitary specific point mutation of codon 201 of the Gs alpha gene in a pituitary adenoma of a patient with multiple endocrine neoplasia (MEN) type 1
Q30842685A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A.
Q36661917A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors
Q85449353A puzzling case of phospho-soda-induced hypocalcemia in a patient with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism
Q40667481A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci.
Q38447520A randomized, prospective trial of operative treatments for hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
Q59539047A rapid and easy method for multiple endocrine neoplasia type 1 mutation detection using conformation-sensitive gel electrophoresis
Q35666683A rare case of juvenile hypertension: coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism.
Q51330111A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Q36445839A rare presentation of multiple endocrine neoplasia (MEN) type 2A syndrome
Q42504048A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience
Q46124876A transcript map encompassing the multiple endocrine neoplasia type-1 (MEN1) locus on chromosome 11q13.
Q24628248A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus
Q54579481A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1.
Q45812930AB 51. Rare case of granular cell tumor of the lung in a patient with multiple endocrine neoplasia syndrome and mass of the left lung.
Q46861482ACTH-secreting thymic carcinoid associated with multiple endocrine neoplasia type 1.
Q94593979ADRENAL INCIDENTALOMA, BREAST CANCER AND UNRECOGNIZED MULTIPLE ENDOCRINE NEOPLASIA TYPE 1
Q38546723AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: TIMING OF MULTIPLE ENDOCRINE NEOPLASIA THYROIDECTOMY AND EXTENT OF CENTRAL NECK LYMPHADENECTOMY.
Q99234303ARMC5 alterations in patients with sporadic neuroendocrine tumors and multiple endocrine neoplasia type 1 (MEN1)
Q34268294Abraham Lincoln's marfanoid mother: the earliest known case of multiple endocrine neoplasia type 2B?
Q74324669Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese
Q50156496Absence of rectoanal inhibitory reflex in a child with multiple endocrine neoplasia type 2B.
Q69916781Absent taeniae coli in multiple endocrine neoplasia type III
Q83456440Abstracts of the 11th International Workshop on Multiple Endocrine Neoplasia, 25-27 September 2008, Delphi, Greece
Q87643708Abstracts of the 14th International Workshop on Multiple Endocrine Neoplasia and Other Rare Endocrine Tumors, September 25th-27th, 2014, Vienna, Austria
Q42440210Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a.
Q41201307Accuracy of 68Ga DOTANOC PET/CT Imaging in Patients With Multiple Endocrine Neoplasia Syndromes.
Q72760356Achalasia of the cardia and multiple endocrine neoplasia 2B
Q45288880Acromegaly caused by growth hormone releasing hormone (GHRH) secreting tumor in multiple endocrine neoplasia (MEN-1).
Q70873712Acromegaly caused by growth hormone-relating hormone in a patient with multiple endocrine neoplasia type I
Q81562465Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease
Q41791118Acute coronary syndrome: a rare case of multiple endocrine neoplasia syndromes with pheochromocytoma and medullary thyroid carcinoma
Q104794552Acute oesophageal necrosis in multiple endocrine neoplasia type 1: an undescribed complication
Q83213109Acute renal failure as an initial manifestation of multiple endocrine neoplasia (MEN) type 1
Q69855910Adenomatous polyposis coli and multiple endocrine neoplasia type 2b. A pathogenetic relationship
Q74119309Adrenal involvement in multiple endocrine neoplasia type 1
Q44521493Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening
Q50593991Adrenal lesion in multiple endocrine neoplasia type 1.
Q41014429Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1.
Q78249635Adrenal medullary calcitonin-like factor: a key to multiple endocrine neoplasia, type 2?
Q40624184Adrenal medullary disease in multiple endocrine neoplasia type 2. Appropriate management
Q71492333Adrenal medullary disease in multiple endocrine neoplasia type II
Q73096155Adult respiratory distress syndrome due to pheochromocytoma as the initial presentation of multiple endocrine neoplasia type IIA syndrome
Q42833744Adult transmural intestinal ganglioneuromatosis is not always associated with multiple endocrine neoplasia or neurofibromatosis: a case report
Q41698173Adult-onset angiofibroma and multiple endocrine neoplasia type I.
Q47569451Advances in risk-oriented surgery for multiple endocrine neoplasia type 2.
Q30319804Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers
Q73701814Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I
Q55071074Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation.
Q42462251Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus
Q46892946Allele loss on chromosome 11 in a pituitary tumor from a patient with multiple endocrine neoplasia type 1.
Q38474599Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors
Q73493517Allelic loss in parathyroid tumors from individuals homozygous for multiple endocrine neoplasia type 1
Q68292855Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1
Q97887342Alu-Mediated MEN1 Gene Deletion and Loss of Heterozygosity in a Patient with Multiple Endocrine Neoplasia Type 1
Q40678637Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma.
Q65536125An Exploratory Study to Assess the Effects of JNJ-39439335 on the Relief of Pain Using a Thermal-Grill Experimental Model
Q54484608An Indian family of multiple endocrine neoplasia type 1 (MEN1): molecular diagnosis, treatment and follow up.
Q49984977An assessment of 18 F-FDG PET/CT for thoracic screening and risk stratification of Pulmonary Nodules in Multiple Endocrine Neoplasia Type 1.
Q36397764An association of multiple endocrine neoplasia 2B, a RET mutation; constipation; and low substance P-nerve fiber density in colonic circular muscle.
Q35198930An efficient strategy for gene mapping using multipoint linkage analysis: exclusion of the multiple endocrine neoplasia 2A (MEN2A) locus from chromosome 13.
Q33747848An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer.
Q71649305An unusual case of multiple endocrine neoplasia type 1 and the role of 111In-pentetreotide scintigraphy
Q72552740An unusual cause of attacks of focal cerebral symptoms: Multiple endocrine neoplasia type IIa
Q73555662An unusual kindred of the multiple endocrine neoplasia type 1 (MEN1) in Japanese
Q72575438An unusual variant of multiple endocrine neoplasia syndrome: a case report
Q47734284Anaesthetic management for laparoscopic bilateral adrenalectomy in MEN2A (Multiple endocrine neoplasia) followed by subsequent total thyroidectomy and radical neck dissection
Q33731640Anaesthetic management of a dopamine-secreting phaeochromocytoma in multiple endocrine neoplasia 2B syndrome
Q69907555Analysis of 13q RFLP in multiple endocrine neoplasia type II kindreds
Q47641378Analysis of MEN1 c.482G>A (p.Gly161Asp) mutation in a pedigree with familial multiple endocrine neoplasia type 1.
Q44489867Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution
Q62000541Analysis of gross deletions in theMEN1gene in patients with multiple endocrine neoplasia type 1
Q45970447Anesthesiologic peculiarities in bilateral pheochromocytoma and suspected multiple endocrine neoplasia
Q36420617Anesthetic considerations in the multiple endocrine neoplasia syndromes.
Q85836354Angiofibromas in multiple endocrine neoplasia type 1
Q42278263Animal model of human disease. Medullary thyroid carcinoma, multiple endocrine neoplasia, Sipple's syndrome. Animal model: ultimobranchial thyroid neoplasm in the bull
Q67652468Application of MEN 203 as a polymorphic DNA probe in screening multiple endocrine neoplasia 2a
Q53152267Application of an intracellular stability test of a novel missense menin mutant to the diagnosis of multiple endocrine neoplasia type 1.
Q41202102Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Q83458784Application of genetic testing to define the surgical approach in a sporadic case of multiple endocrine neoplasia type 1
Q37879781Are microRNAs involved in the endocrine-specific pattern of tumorigenesis in multiple endocrine neoplasia type 1?
Q34064454Are patients with multiple endocrine neoplasia type I prone to premature death?
Q39052046Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process
Q81797093Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations
Q65336442Association Between Heat Pain Detection Threshold and Area of Secondary Hyperalgesia
Q55034425Association of medullary sponge kidney disease and multiple endocrine neoplasia type IIA due to RET gene mutation: is there a causal relationship?
Q45094261Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.
Q36508938Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.
Q51420518Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
Q54600815Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor.
Q42860788Atypical carcinoid of thymus associated with multiple endocrine neoplasia syndrome type 1
Q84039260Atypical clinical manifestations of multiple endocrine neoplasia type 1 syndrome
Q91283832Atypical ovarian carcinoid tumor with widespread skeletal metastases: a case report of multiple endocrine neoplasia type 1 in a young woman
Q79272406Atypical presentation of pheochromocytoma as part of multiple endocrine neoplasia IIa in pregnancy
Q51668899Atypical thymic carcinoid and malignant somatostatinoma in type I multiple endocrine neoplasia syndrome: case report.
Q81235135Atypical thymic carcinoid in multiple endocrine neoplasia type 1 syndrome
Q43847554Autogenous parathyroid grafts for generalized primary parathyroid hyperplasia: contrasting outcome in sporadic hyperplasia versus multiple endocrine neoplasia type I.
Q81143120Autopsy case of prostate cancer with multiple endocrine neoplasia 2A
Q64352496Barbershop Talk: HIV Prevention for African American Heterosexual Men
Q42468715Basal and postatropine serum pancreatic polypeptide concentrations in familial multiple endocrine neoplasia type I.
Q26781862Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease
Q51606712Benefit of resection of metastatic gastrinoma in multiple endocrine neoplasia type I.
Q85937839Better Survival But Changing Causes of Death in Patients With Multiple Endocrine Neoplasia Type 1
Q58124596Bilateral Medullary Thyroid Carcinoma in a 3-Year-Old Female Patient with Multiple Endocrine Neoplasia 2A Syndrome Undergoing Prophylactic Thyroidectomy: Should Current Guidelines Be Revised?
Q41102489Bilateral adrenalectomy with autotransplantation of adrenocortical tissue or unilateral adrenalectomy: treatment options for pheochromocytomas in multiple endocrine neoplasia type 2A.
Q34576778Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene.
Q90794744Bilateral giant parathyroid adenoma in the absence of multiple endocrine neoplasia type 1
Q35111480Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion
Q70782484Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome)
Q34252144Bilateral pheochromocytoma in pregnancy heralding multiple endocrine neoplasia syndrome IIA. A case report.
Q73933513Bilateral pituitary adenomas occurring with multiple endocrine neoplasia type one
Q57644639Bilateral submandibular gland oncocytoma in a patient with multiple endocrine neoplasia 2B syndrome and neurofibromatosis type 1: an unusual case
Q30403102Bilateral subtotal adrenal resection for bilateral pheochromocytomas in multiple endocrine neoplasia, type IIa: a case report
Q37378933Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome
Q104674992Bioavailability of Anthocyanins From Aronia Extract in Healthy Men - a Pilot Study
Q34744922Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients
Q46097041Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
Q46000464Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy.
Q48732923Brain metastasis from pheochromocytoma in a patient with multiple endocrine neoplasia type 2A.
Q34567651Breast-cancer predisposition in multiple endocrine neoplasia type 1.
Q28588869Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1
Q38538216Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1.
Q35990387Bronchopulmonary carcinoid in multiple endocrine neoplasia type 1.
Q39824843C-cell disease of the thyroid gland in multiple endocrine neoplasia, type 2B
Q72179289CD15 (LeuM1) immunoreactivity: prognostic factor for sporadic and hereditary medullary thyroid cancer? Study Group on Multiple Endocrine Neoplasia of Austria
Q92841800CO-EXISTENCE OF PRIMARY HYPERPARATHYROIDISM DUE TO MULTIPLE ENDOCRINE NEOPLASIA 1 IN A HYPERCALCEMIC PATIENT WITH GRAVES DISEASE
Q72559063CT of the pituitary gland in multiple endocrine neoplasia type 1 syndrome
Q64092002CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases
Q104072802Calcific pancreatitis uncovering a multiple endocrine neoplasia type 1: A case report in compliance with the scare guidelines
Q47176375Can We Do Even Better? Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
Q57423383Candidate genes for multiple endocrine neoplasia type 1
Q53331469Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome.
Q72395916Carcinoid tumor of the lung and type-1 multiple endocrine neoplasia associated with persistent hypercalcemia: a case report
Q69875280Carcinoid tumor of the pancreas causing the diarrheogenic syndrome: report of a case combined with multiple endocrine neoplasia, type I
Q72549665Carcinoid tumor of the thymus with multiple endocrine adenomatosis
Q69902407Carcinoids associated with multiple endocrine neoplasia syndromes
Q37808142Care for patients with multiple endocrine neoplasia type 1: the current evidence base
Q43761939Case of multiple endocrine neoplasia 2B with probable ectopic adrenocorticotropic hormone-secreting liver metastasis from medullary thyroid carcinoma
Q42782779Case of thymic carcinoid associated with multiple endocrine neoplasia type I treated effectively with chemotherapy
Q68325678Catecholamine-Induced Cardiomyopathy in Multiple Endocrine Neoplasia
Q72220849Cause of death in multiple endocrine neoplasia type 1
Q37739836Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1.
Q37056120Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors
Q48299340Cerebral Aneurysm Associated with Multiple Endocrine Neoplasia, Type 1 —Case Report—
Q69871451Cerebral haemorrhage in a pregnant woman with a multiple endocrine neoplasia syndrome (type 2A or Sipple's syndrome)
Q46224682Cervical metastases of glucagonoma in a patient with multiple endocrine neoplasia type 1: report of a case
Q33874708Challenging Differential Diagnosis of Hypergastremia and Hyperglucagonemia with Chronic Renal Failure: Report of a Case with Multiple Endocrine Neoplasia Type 1
Q37045737Characteristics of chronic megacolon among patients diagnosed with multiple endocrine neoplasia type 2B.
Q50543268Characteristics of the Danish families with multiple endocrine neoplasia type 1.
Q46139659Characterization of RET proto-oncogene C634Y mutation in a Moroccan family with multiple endocrine neoplasia type 2A
Q24538768Characterization of mutations in patients with multiple endocrine neoplasia type 1.
Q66046382Check it: A New Approach to Controlling Chlamydia Transmission in Young People
Q90843428Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1)
Q34775610Chiari-Frommel syndrome as a part of the Zollinger-Ellison multiple endocrine adenomatosis complex
Q95591415Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment (PDQ®): Health Professional Version
Q95591394Childhood Multiple Endocrine Neoplasia (MEN) Syndromes Treatment (PDQ®): Patient Version
Q78384282Choroidal metastasis from medullary thyroid carcinoma in multiple endocrine neoplasia
Q79096275Choroidal metastasis from medullary thyroid carcinoma in multiple endocrine neoplasia
Q72550407Chromosomal breakage in multiple endocrine adenomatosis (types I and II)
Q72628493Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test
Q36258020Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study
Q68295024Chromosome abnormalities in lymphocytes and fibroblasts of subjects with multiple endocrine neoplasia type 1
Q85675298Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1)
Q72879052Circulating fibroblast growth factor-like autoantibodies in two patients with multiple endocrine neoplasia type 1 and prolactinoma
Q44401056Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1.
Q65385074Clinical & Web-based Diet & Activity Counseling for Men
Q68315199Clinical Characteristics in Multiple Endocrine Neoplasia Type 1 in Japan: A review of 106 patients
Q93125830Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases
Q38867386Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center
Q28553509Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese
Q67518300Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1
Q68724834Clinical and genetic investigation of a large kindred with multiple endocrine adenomatosis
Q34302438Clinical and molecular aspects of multiple endocrine neoplasia type 1.
Q34577511Clinical and molecular diagnosis of multiple endocrine neoplasia type 1.
Q42444529Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A.
Q74068468Clinical aspects of hyperparathyroidism in Japanese multiple endocrine neoplasia type 1
Q47875864Clinical features and anesthetic management of multiple endocrine neoplasia associated with pheochromocytoma
Q47630399Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis.
Q84564204Clinical features of insulinoma in patients with multiple endocrine neoplasia type 1: analysis of the database of the MEN Consortium of Japan
Q53914105Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: analysis of 20 Japanese sporadic cases with MEN1.
Q35278650Clinical features of multiple endocrine neoplasia type 1 and type 2
Q47768404Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1).
Q42681836Clinical management of the multiple endocrine neoplasia syndromes: results of a computerized opinion poll at the Sixth International Workshop on Multiple Endocrine Neoplasia and von Hippel-Lindau disease
Q34283436Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).
Q93077078Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1
Q51713182Clinical significance of RET mutation screening in a pedigree of multiple endocrine neoplasia type 2A.
Q39245542Clinical significance of hyperparathyroidism in familial multiple endocrine adenomatosis type I (MEA I)
Q71777163Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
Q39239455Clinical studies on familial multiple endocrine adenomatosis type II (author's transl)
Q54680442Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory.
Q39701094Clinical utility gene card for: multiple endocrine neoplasia type 2.
Q72595009Clinical value of tumor doubling estimations in multiple endocrine neoplasia type II
Q30572660Clinicogenetic study of MEN1: recent physiopathological data and clinical applications. Study Group of Multiple Endocrine Neoplasia (GENEM)
Q70119460Clinicopathologic conference. Multiple endocrine adenomatosis
Q73141672Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1
Q91825938Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1
Q34101198Clinicopathological features of multiple mucosal neuroma without multiple endocrine neoplasia type IIB
Q28257084Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1
Q94587117Clues for genetic anticipation in Multiple Endocrine Neoplasia type 1
Q90583692Co-occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes
Q89689707Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report
Q30320251Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2.
Q48145845Coexistence of GH-Producing Pituitary Macroadenoma and Meningioma in a Patient with Multiple Endocrine Neoplasia Type 1 with Hyperglycemia and Ketosis as First Clinical Sign
Q54581150Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family.
Q69886771Coexistence of sporadic multiple endocrine neoplasia and scapular ectopic breast. Coincidence or biologically associated?
Q47598649Coexisting Thymic and Pulmonary Carcinoid Tumors Associated with Multiple Endocrine Neoplasia Type1.
Q43902004Coexisting acromegaly and a unilateral cortisol-producing adrenal adenoma: a possible variant of multiple endocrine neoplasia type I
Q33744202Cognitive behavioural therapy for depression in multiple endocrine neoplasia type IIB: a 1-year follow-up.
Q81462616Coincidence of multiple endocrine neoplasia type IIa and type 1 diabetes mellitus
Q81712872Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism
Q54648670Collision of extensive exocrine and neuroendocrine neoplasms in multiple endocrine neoplasia type 1 revealed by cytogenetic analysis of loss of heterozygosity: a case report.
Q39236979Colonic and Oesophageal Disturbance in a Patient with Multiple Endocrine Neoplasia, Type 2b
Q83182527Combination of multiple skin malignancies with multiple endocrine neoplasia type 1: coincidental or pathogenetically related?
Q94459152Combined 68Ga-DOTATOC and 18F-FDG PET Predicts a Double Component With Different Grade of a Pancreatic Neuroendocrine Tumor in a Patient With Multiple Endocrine Neoplasia Type 1
Q42144447Combined multiple endocrine neoplasia (MEN I and MEN IIa)
Q92656344Comment on: "In Vivo Confocal Microscopy of Prominent Conjunctival and Corneal Nerves in Multiple Endocrine Neoplasia Type 2B"
Q43494900Commentary on "Better Survival But Changing Causes of Death in Patients With Multiple Endocrine Neoplasia Type 1".
Q54287604Comparative genomic hybridization studies in tumours from a patient with multiple endocrine neoplasia type 1.
Q63841685Comparing Effects of Diet, With or Without Exercise, on Sexual, Urinary and Endothelial Function, Inflammatory Profile and Quality of Life in Obese Men
Q99557796Comparison of 68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome
Q46234692Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome
Q39130373Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Q73113183Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2--a plea to conserve adrenal function
Q74501846Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA
Q71960378Composite pheochromocytoma/ganglioneuroma of the adrenal gland associated with multiple endocrine neoplasia 2A: case report with immunohistochemical analysis
Q96823194Comprehensive treatment of rare multiple endocrine neoplasia type 1: A case report
Q28138822Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1)
Q90875819Concomitant Thyroid Cancer in Patients with Multiple Endocrine Neoplasia Type 1 Undergoing Surgery for Primary Hyperparathyroidism
Q37217944Concomitant existence of pheochromocytoma in a patient with multiple endocrine neoplasia type 1.
Q74600531Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis
Q64996191Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
Q36461868Confocal scan imaging and impression cytology of the cornea in a case of multiple endocrine neoplasia type-2b.
Q71752645Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II
Q40137988Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra
Q34438169Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.
Q90108452Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1
Q68087543Contrast MRI in multiple endocrine neoplasia type 1 (MEN) associated with renal cell carcinoma
Q63815918Controlled Randomized Study With Athena Base Plate Versus SenSura Base Plate on Perspiring Skin
Q38555421Corneal xanthogranuloma in association with multiple endocrine neoplasia 1: A clinicopathologic case report and review of the literature
Q93637706Correction for Pellegata et al., Germ-line mutations in p27 cause a multiple endocrine neoplasia syndrome in rats and humans
Q56363462Correction to: Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database
Q53227787Correlation of mutant menin stability with clinical expression of multiple endocrine neoplasia type 1 and its incomplete forms.
Q53872390Cortical-sparing laparoscopic adrenalectomy in a patient with multiple endocrine neoplasia type IIA.
Q46346153Cost analysis of DNA-based testing in a large Canadian family with multiple endocrine neoplasia type 2.
Q64120689Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism?
Q35987860Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines
Q40712334Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I.
Q74817194Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both
Q58327462Cushing Syndrome Secondary to a Thymic Carcinoid Tumor Due to Multiple Endocrine Neoplasia Type 1
Q79369748Cushing's disease as the first clinical manifestation of multiple endocrine neoplasia type 1 (MEN1) associated with an R460X mutation of the MEN1 gene
Q35978510Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1.
Q35627049Cushing's syndrome in multiple endocrine neoplasia type 1.
Q94698774Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1
Q71874026Cutaneous macular amyloidosis associated with multiple endocrine neoplasia 2A
Q79916229Cutaneous metastasis of pheochromocytoma in multiple endocrine neoplasia IIB
Q34746775Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene.
Q73444040Cystic glucagonoma with loss of heterozygosity on chromosome 11 in multiple endocrine neoplasia type 1
Q72683721Cystic insulinoma and nonfunctioning islet cell tumor in multiple endocrine neoplasia type 1
Q52832738Cytogenetic and CGH studies of four neuroendocrine tumors and tumor-derived cell lines of a patient with multiple endocrine neoplasia type 1.
Q72090528Cytogenetic studies in sporadic and multiple endocrine neoplasia type 1‐associated pituitary adenomas
Q33765219Cytogenetic studies of individuals from four kindreds with multiple endocrine neoplasia type II syndrome
Q69928920Cytogenetical investigations in patients with primary hyperparathyroidism and multiple endocrine neoplasia type 1
Q67522708Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MEN1
Q67515096Cytogenetics of multiple endocrine neoplasia syndromes. I. Two different, unique clonal chromosome changes in a medullary thyroid carcinoma and in a C-cell thyroid hyperplasia
Q36742043Cytogenetics of multiple endocrine neoplasia syndromes. III. Analysis of an insulinoma from a subject with MEN 1 by chromosome painting
Q65345218Degradation of the Anorexic Hormone Peptide YY
Q51355909Delay in the diagnosis of multiple endocrine neoplasia type 1: typical symptoms are frequently overlooked.
Q68089804Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA
Q50902860Dental rehabilitation of the patient with multiple endocrine neoplasia Type 2b.
Q54544183Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
Q77965954Detection of a novel nonsense mutation of the MEN1 gene in a familial multiple endocrine neoplasia type 1 patient and its screening in the family members
Q106637905Determining the Effectiveness of Working Out Dads to Reduce Mental Health Difficulties in Fathers of Young Children
Q31127937Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.
Q39573905Diagnosis and Management of Multiple Endocrine Neoplasia Type 1 (MEN1).
Q37016985Diagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1).
Q71540782Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene
Q37493943Diagnosis and surgical treatment of multiple endocrine neoplasia type 2A.
Q37254699Diagnosis by serendipity: Cushing syndrome attributable to cortisol-producing adrenal adenoma as the initial manifestation of multiple endocrine neoplasia type 1 due to a rare splicing site MEN1 gene mutation
Q71532401Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations
Q94078439Diagnosis: Multiple endocrine neoplasia type 1 (MEN 1), also known as Wermer’s syndrome
Q42458826Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1.
Q60021310Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1)
Q66072682Dietary Guide in Active Older Adult Men
Q36528838Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Q73793451Different phenotypes of multiple endocrine neoplasia type 1 (MEN1) in monozygotic twins found in a Japanese MEN1 family with MEN1 gene mutation
Q46381321Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas
Q36682496Difficulties in localization and treatment of insulinomas in type 1 multiple endocrine adenomatosis (MEA)
Q84327046Diffuse corneoscleral limbal neuromas with prominent corneal nerves in multiple endocrine neoplasia syndrome type IIB
Q80380178Diffuse gastric carcinoid polyposis in multiple endocrine neoplasia 1 syndrome without hypergastrinemia
Q39157256Dilemmas in the early diagnosis and treatment of multiple endocrine adenomatosis, type II
Q83520362Direct molecular diagnosis of multiple endocrine neoplasia type 1
Q50053901Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I.
Q50752866Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Q51081732Distress in MEN 2 family members and partners prior to DNA test disclosure. Multiple endocrine neoplasia type 2.
Q40491580Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide Study
Q69913121Diverticulitis in the multiple endocrine neoplasia type II B syndrome
Q47361704Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening?
Q72597957Dopamine control of prolactin secretion in multiple endocrine neoplasia type I
Q50251481Dr Dickinson Ober Wheelock--a case of sporadic insulinoma or multiple endocrine neoplasia type 1?
Q33921582Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
Q73263319Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas
Q50599727EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
Q44432098Early detection of medullary thyroid carcinoma in multiple endocrine neoplasia type II
Q57436762Early diagnosis of multiple endocrine neoplasia type IIa
Q57650175Early diagnosis of multiple endocrine neoplasia type IIa
Q39117474Early markers for the multiple endocrine neoplasia syndromes.
Q77898380Early onset of medullary thyroid carcinoma in a kindred with multiple endocrine neoplasia type iia associated with cutaneous lichen amyloidosis
Q64459168Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: Implications for therapy
Q34319009Early surgical intervention and strategy in patients with multiple endocrine neoplasia type 1.
Q95943719Early thyroidectomy in multiple endocrine neoplasia: a four decade experience
Q42494980Early total thyroidectomy in patients with multiple endocrine neoplasia IIb syndrome
Q43819872Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.
Q87946851Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes
Q48960945Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
Q83482732Education and imaging. Hepatobiliary and pancreatic: pancreatic VIPomas associated with multiple endocrine neoplasia type I
Q66083593Effect of PROGRESSive Training and Teststerone in Older Frail Men
Q65364394Effect of Pumpkin Seed Oil on Hair Growth in Men With Androgenetic Alopecia
Q47232369Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations
Q42504359Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.
Q46591751Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients
Q85486744Effective perioperative management of multiple endocrine neoplasia type 1-associated insulinomas
Q65391375Effectiveness of HIV Risk Reduction Program Among African American Men
Q64672050Effects of Diet-induced Weight Loss in Obese Men
Q66343204Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old
Q65545262Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health
Q37249732Effects of age, sex and multiple endocrine neoplasia type-II on silver stained nucleolar organizer regions
Q65364333Effects of the Mediterranean Diet on Cardiovascular Risk Profile in Men and Women (ALIMED)-Part 2
Q40515095Efficacy and Long-Term Safety of Everolimus in Pancreatic Neuroendocrine Tumor Associated with Multiple Endocrine Neoplasia Type I: Case Report
Q65354853Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
Q48041395Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region
Q39871949Embolization as an alternative treatment of insulinoma in a patient with multiple endocrine neoplasia type 1 syndrome
Q37050064Endocrine surgical aspects of multiple endocrine neoplasia syndromes in children
Q46931054Endocrine tumors of the pancreas (EPTs) in multiple endocrine neoplasia (MEN1): up-date on prognostic factors, diagnostic procedures and treatment
Q39469293Endocrine-skin interactions. Cutaneous manifestations of adrenal disease, pheochromocytomas, carcinoid syndrome, sex hormone excess and deficiency, polyglandular autoimmune syndromes, multiple endocrine neoplasia syndromes, and other miscellaneous d
Q52560917Endoscopic Ultrasound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study.
Q81364288Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1
Q74068553Enhanced sensitivity to alkylating agent in lymphocytes from patients with multiple endocrine neoplasia type 1
Q47741330Enteropancreatic malignancy associated with multiple endocrine neoplasia type 1: risk factors and pathogenesis
Q46227275Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.
Q37730726Ependymoma and carcinoid tumor associated with ovarian mature cystic teratoma in a patient with multiple endocrine neoplasia I.
Q73680718Epistaxis as presentation of multiple endocrine neoplasia type I
Q44651420Establishment and characterization of mouse mammary carcinoma cell lines expressing RET with a multiple endocrine neoplasia 2A mutation
Q36688044Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A.
Q68158149Evaluation of children with multiple endocrine neoplasia type IIb following thyroidectomy
Q40277135Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.
Q38991268Evidence for the founder effect of RET533 as the common Greek and Brazilian ancestor spreading multiple endocrine neoplasia 2A.
Q67323570Evidence of multicentric origin of the multiple endocrine neoplasia syndrome type 2a (Sipple's syndrome) in a large family in the Netherlands. Diagnostic and therapeutic implications
Q37767074Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.
Q58862224Exclusion of FAU as the Multiple Endocrine Neoplasia type 1 (MEN1) gene
Q38346423Exclusion of ZFM1 as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).
Q70338520Exclusion of linkage between the loci for multiple endocrine neoplasia type-2 (MEN-2) and HLA
Q57423385Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1
Q48054305Exclusion of the nuclear factor-kappa B3 (REL A) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene
Q72997882Exclusion of the phosphatidylinositol-specific phospholipase C beta 3 (PLC beta 3) gene as candidate for the multiple endocrine neoplasia type 1 (MEN 1) gene
Q61964010Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1
Q57423377Exclusion of the phosphoinositide-specific phospholipase C?3 ( PLCB3 ) gene as a candidate for multiple endocrine neoplasia type 1
Q66073835Exercise Duration Models, in Middle-aged Men
Q40482052Experience with multiple endocrine neoplasia type 1 screening
Q35082433Exploring the tumors of multiple endocrine neoplasia type 1 in mouse models for basic and preclinical studies
Q73527291Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues
Q51788318Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene.
Q72523312Expression of basic fibroblast growth factor in hyperplastic parathyroid glands from patients with multiple endocrine neoplasia type I
Q73931806Expression of multiple endocrine neoplasia 2B RET in neuroblastoma cells alters cell adhesion in vitro, enhances metastatic behavior in vivo, and activates Jun kinase
Q47406051Expression of p27(Kip1) and p18(Ink4c) in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors.
Q42490841Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Q74817185Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1
Q81386576Facial angiofibroma as an initial manifestation in multiple endocrine neoplasia type 1
Q72431946Failure of Cimetidine to Affect Calcium Homeostasis in Familial Primary Hyperparathyroidism (Multiple Endocrine Neoplasia, Type 1)*
Q28254996Failure to recognize multiple endocrine neoplasia 2B: more common than we think?
Q42436397False-positive results of basal and pentagastrin-stimulated calcitonin in non-gene carriers of multiple endocrine neoplasia type 2A.
Q51166632Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred.
Q77388243Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma: a case report with clinicopathologic and molecular analyses
Q50565408Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree.
Q33680543Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia
Q34309125Familial isolated primary hyperparathyroidism--a multiple endocrine neoplasia type 1 variant?
Q72536823Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatment
Q54040308Familial multiple endocrine adenomatosis. Multiple endocrine neoplasia, type I.
Q48768521Familial multiple endocrine neoplasia syndromes: components, classification, and nomenclature
Q81080049Familial multiple endocrine neoplasia type 1 Mutation of a tumor suppressor gene
Q69932244Familial multiple endocrine neoplasia type I
Q67431236Familial multiple endocrine neoplasia type I (Wermer's syndrome)
Q39465392Familial multiple endocrine neoplasia type I: a new look at pathophysiology
Q81192432Familial multiple endocrine neoplasia type I: the urologist is first on the scene
Q34383711Familial multiple endocrine neoplasia: the first 100 years
Q68760865Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis
Q72542687Familial studies in medullary thyroid carcinoma and multiple endocrine adenomatosis
Q37074258Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report
Q68702839Fasting hypoglycemia, hypercalcemia and hyperprolactinemia. Multiple endocrine neoplasia, type 1?
Q33497357Fatal thrombotic thrombocytopenic purpura (TTP) presenting concurrently with metastatic multiple endocrine neoplasia (MEN) type I.
Q90452319Features of Multiple Endocrine Neoplasia Type 1 and 2A in a Patient with Both RET and MEN1 Germline Mutations
Q73423536Fibroblast growth factor-like autoantibodies in plasma from patients with multiple endocrine neoplasia type 1 and prolactinoma
Q50036480Financial burden is associated with worse health-related quality of life in adults with multiple endocrine neoplasia type 1.
Q67522383Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1
Q35195084Fine-scale mapping of the gene responsible for multiple endocrine neoplasia type 1 (MEN 1)
Q37178222First description of parathyroid disease in multiple endocrine neoplasia 2A syndrome
Q96018793First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans
Q91288819First report of concomitant pheochromocytoma and duodenal neuroendocrine tumour in a sporadic multiple endocrine neoplasia type 1
Q73413408Five novel mutations in the familial multiple endocrine neoplasia type 1 (MEN1) gene. Mutations in brief no. 188. Online
Q47819138Founder Effect of the RETC611Y Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide Study
Q89486283French comment on article Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study
Q44862214Frequency of facial angiofibromas in Japanese patients with multiple endocrine neoplasia type 1.
Q57149373Frequent Occurrence of an Intron 4 Mutation in Multiple Endocrine Neoplasia Type 1
Q60021511Frequent Occurrence of an Intron 4 Mutation in Multiple Endocrine Neoplasia Type 1
Q73393854From diagnosis to treatment: multiple endocrine neoplasia (MEN)
Q43834054From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma
Q39729032Functional Imaging of Pheochromocytoma with Ga-DOTATOC and C-HED in a Genetically Defined Rat Model of Multiple Endocrine Neoplasia
Q47296199Functional analysis of RET with multiple endocrine neoplasia type 2.
Q47159773Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).
Q34520146Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?
Q84506094Gastric masses in multiple endocrine neoplasia type I-associated Zollinger-Ellison syndrome
Q42503049Gastric secretion and hormonal interactions in multiple endocrine neoplasia type I.
Q34531490Gastrin cell function in familial multiple endocrine neoplasia type I
Q92088609Gastrinoma in multiple endocrine neoplasia type 1 after total pancreatectomy: A case report
Q36506071Gastrinoma in multiple endocrine neoplasia type 1.
Q57652719Gastrinoma of Cystic Duct: A Rare Association With Multiple Endocrine Neoplasia Type 1
Q68084123Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome
Q37017018Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1
Q70045590Gastrointestinal cancer syndromes. Gastrins, multiple endocrine adenomatosis, and the Zollinger-Ellison syndrome
Q33425148Gastrointestinal manifestations of multiple endocrine neoplasia type 2.
Q72550977Gastrointestinal manifestations of multiple endocrine neoplasia, type IIB
Q89942738Gender Differences in Multiple Endocrine Neoplasia Type 1: Implications for Screening?
Q33983834Gene diagnosis and clinical management of multiple endocrine neoplasia type 1 (MEN1).
Q47711803Gene dose mapping delineated boundaries of a large germline deletion responsible for multiple endocrine neoplasia type 1.
Q68323985Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation
Q46180745Gene symbol: MEN1. Disease: Multiple endocrine neoplasia 1.
Q45372598Gene symbol: MEN1. Disease: Multiple endocrine neoplasia type 1.
Q38377856Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutation
Q50026136Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutation.
Q42830732Generation of non-integrated induced pluripotent stem cells from a 23-year-old male with multiple endocrine neoplasia type 1 syndrome
Q38708190Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome
Q95924774Generation of three induced pluripotent stem cell (iPSC) lines from a multiple endocrine neoplasia type 1 (MEN1) patient and three iPSC lines from an unaffected relative of the patient
Q33879963Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1
Q40735434Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A.
Q51042142Genetic analysis of a Chinese Han family with multiple endocrine neoplasia type 2A.
Q42227203Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing
Q68308356Genetic and Clinical Characteristics OF Multiple Endocrine Neoplasia Type 1
Q43470115Genetic and clinical analysis in 10 Spanish patients with multiple endocrine neoplasia type 1.
Q41667928Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.
Q42757996Genetic and epigenetic analysis in korean patients with multiple endocrine neoplasia type 1.
Q40428894Genetic aspects of multiple endocrine neoplasia types 1 and 2
Q40442961Genetic basis of endocrine disease: multiple endocrine neoplasia type 2
Q46936847Genetic confirmation that ependymoma can arise as part of multiple endocrine neoplasia type 1 (MEN1) syndrome.
Q43677475Genetic diagnosis in multiple endocrine neoplasia type 2A
Q72056439Genetic mapping of the multiple endocrine neoplasia type 1 locus at 11q13
Q36800237Genetic mapping studies of 40 loci and 23 cosmids in chromosome 11p13-11q13, and exclusion of mu-calpain as the multiple endocrine neoplasia type 1 gene
Q47250187Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report.
Q41545196Genetic screening for RET mutations in families with multiple endocrine neoplasia 2 syndromes
Q34167625Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how
Q40899168Genetic screening for multiple endocrine neoplasia type 2.
Q55003069Genetic screening in hereditary multiple endocrine neoplasia type 1: absence of a founder effect among Japanese families.
Q35908958Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1.
Q71827858Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome
Q33673648Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1
Q38493262Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story
Q71450372Genetic testing for multiple endocrine neoplasia
Q72233567Genetic testing for multiple endocrine neoplasia
Q51770676Genetic testing for multiple endocrine neoplasia type 2.
Q47837111Genetic testing in multiple endocrine neoplasia and related syndromes.
Q40650695Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II.
Q42506209Genetic, clinical, and biochemical analysis of unrelated Spanish families with multiple endocrine neoplasia type I.
Q38801763Genetics of Multiple Endocrine Neoplasia Type 1/Multiple Endocrine Neoplasia Type 2 Syndromes
Q39129029Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old.
Q40642535Genetics of multiple endocrine neoplasia type 1.
Q74243372Genotype-phenotype analysis in multiple endocrine neoplasia type 1
Q50086662Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution
Q37408950Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management
Q73351512Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas
Q34386474Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders
Q24679314Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans
Q34334980Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
Q53921552Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1).
Q42271393Germline and somatic genetic changes in multicentric tumors obtained from a patient with multiple endocrine neoplasia type 1.
Q93339369Germline and somatic mosaicism in a family with multiple endocrine neoplasia type 1 (MEN1) syndrome
Q28277773Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1)
Q57492319Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing
Q77929773Germline mutation of the RET proto-oncogene in members of Slovak families with multiple endocrine neoplasia 2
Q77965881Germline mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in a family with primary hyperparathyroidism
Q53312970Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
Q57419728Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast–ovarian cancer syndromes: a case report
Q74631774Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects
Q62000537Germline mutations in theCDKN1Bgene encoding p27Kip1are a rare cause of multiple endocrine neoplasia type 1
Q55099861Germline mutations of the MEN1 gene in Japanese kindred with multiple endocrine neoplasia type 1.
Q38520214Germline mutations of the MEN1 gene in Korean families with multiple endocrine neoplasia type 1 (MEN1) or MEN1-related disorders
Q73494435Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states
Q43186446Gestational diabetes leading to diagnosis and management of multiple endocrine neoplasia type 2a.
Q48702046Ghrelin expression in neuroendocrine tumours of the gastrointestinal tract with multiple endocrine neoplasia type 1.
Q90290355Giant Prolactinoma Causing Hydrocephalus and Intracranial Hypertension as First Manifestations of Multiple Endocrine Neoplasia Type 1
Q42540766Giant serpentine aneurysm in a patient with multiple endocrine neoplasia type 1 syndrome
Q40580819Gigantism in sibling unrelated to multiple endocrine neoplasia: case report
Q69883826Glomus tumor and multiple endocrine neoplasia
Q57794599Gonadotroph Tumor Associated with Multiple Endocrine Neoplasia Type 1
Q46407352Gonadotroph adenoma in multiple endocrine neoplasia type 1.
Q67518195Gonadotrophin secretion in vitro by cells of a pituitary tumour from a patient with multiple endocrine neoplasia type I
Q70290671Granular-cell pituicytoma associated with multiple endocrine neoplasia type
Q34129540Growth hormone overproduction in a patient with multiple endocrine neoplasia type I.
Q69907365Growth hormone-releasing hormone (GHRH)-secreting pancreatic tumor in a patient with multiple endocrine neoplasia type I
Q73562609Growth hormone-releasing hormone (GRH)-producing pancreatic tumor with no evidence of multiple endocrine neoplasia type 1
Q62579280Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype
Q51327209Growth rate of small pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: results from an endoscopic ultrasound based cohort study.
Q71886592Gs alpha mutation may be uncommon in patients with multiple endocrine neoplasia type 1
Q65349096HIV & Drug Abuse Prevention for South African Men
Q64707721HIV Prevention Program for African American Teen Males
Q39259920HLA in Multiple Endocrine Adenomatosis (Type I)
Q66390466HPV Vaccine Intervention for Young Sexual Minority Men
Q48806758Haploinsufficient and predominant expression of multiple endocrine neoplasia type 1 (MEN1)-related genes, MLL, p27Kip1 and p18Ink4C in endocrine organs
Q73148757Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene
Q94513283Health-related quality of life in patients with Multiple Endocrine Neoplasia type 1
Q64675325Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
Q69882604Hemothorax disclosing hemorrhagic necrosis of a pheochromocytoma: circumstance for detection of multiple endocrine neoplasia type IIa. Detection of 5 familial cases
Q44803097Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1
Q47422220Heterogeneous size of the parathyroid glands in familial multiple endocrine neoplasia type 1.
Q81566739Heterotropic cardiac calcification: a rare presentation of multiple endocrine neoplasia
Q73557853Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1
Q88010151Hibernoma and multiple endocrine neoplasia type 1 syndrome: A non-fortuitous association? A case report and literature review
Q35787196Hibernomas are characterized by homozygous deletions in the multiple endocrine neoplasia type I region. Metaphase fluorescence in situ hybridization reveals complex rearrangements not detected by conventional cytogenetics
Q57778874High Fear of Disease Occurrence Is Associated With Low Quality of Life in Patients With Multiple Endocrine Neoplasia Type 1: Results From the Dutch MEN1 Study Group
Q54449192High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.
Q58603289High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy
Q33862888High resolution chromosome and DNA analysis in multiple endocrine neoplasia type II syndrome
Q44655440Hiob syndrome. A case report of multiple endocrine neoplasia
Q34707385Hirschsprung's disease in a family with multiple endocrine neoplasia type 2.
Q71500281Histologic study of the ocular lesions in multiple endocrine neoplasia syndrome type IIb
Q96168576History of the multiple endocrine neoplasia workshops and overview of MEN2019
Q64395450Hockey Fans in Training (Hockey FIT): A Pilot Pragmatic Randomized Controlled Trial
Q64647804How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months?
Q80166386How effective is prophylactic thyroidectomy in asymptomatic multiple endocrine neoplasia type 2A?
Q37529908How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed?
Q87640196How to follow up and when to operate asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1?
Q46213497Human gene mutations. Gene symbol: MEN1. Disease: MEN1, multiple endocrine neoplasia, Type 1.
Q90783527Hyperandrogenism in a child with multiple endocrine neoplasia type 1
Q38364336Hypercalcemia in the multiple endocrine neoplasia syndromes
Q68292790Hypercalcitoninemia and adrenal mass in a woman with multiple endocrine neoplasia type IIA
Q45034203Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1.
Q69887360Hypernephroma associated with multiple endocrine neoplasia type I: a case report
Q46148043Hyperparathyroidism in multiple endocrine neoplasia syndrome
Q74556160Hyperparathyroidism in multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe D'etude des Néoplasies Endocriniennes Multiples Study Group
Q71568250Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression
Q69897298Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1
Q72664118Hyperparathyroidism with chronic parathyroiditis in a multiple endocrine neoplasia patient
Q45104173Hyperparathyroidism with normal albumin-corrected total calcium in patients with multiple endocrine neoplasia type 1.
Q40083257Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature
Q66706463Hyperprolactinemia and the Multiple Endocrine Adenomatosis Type 1 (MEA-1) Syndrome
Q39221047Hyperprolactinemia in Multiple Endocrine Adenomatosis, Type 1
Q72576555Hyperprolactinemia without pituitary adenoma in multiple endocrine neoplasia type IIa
Q64040958Hypertension and intrapericardial paraganglioma: an exceptional presentation of multiple endocrine neoplasia type IIA syndrome
Q28277763Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene
Q91992138Identification of Novel Variants in MEN1: A Study Conducted with Four Multiple Endocrine Neoplasia Type 1 Patients
Q101565708Identification of a novel frameshift c.930delG MEN1 germline mutation (p.Glu273LysfsTer7) in a sporadic case of multiple endocrine neoplasia type 1: A case report
Q33681517Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families
Q43806908Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism
Q28243243Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1
Q73593629Identification of three novel menin mutations (c.741delGTCA, c.1348T>C, c.1785delA) in unrelated Italian families affected with multiple endocrine neoplasia type 1: Additional information for mutational screening
Q77598692Images in clinical medicine. Tumors of the pituitary, pancreas, and parathyroid glands in a patient with multiple endocrine neoplasia type 1
Q80309279Images of interest. Gastrointestinal: multiple endocrine neoplasia type I and duodenal gastrinomas
Q96641851Imaging and Diagnostic Challenges in a Patient With Refractory Hypoglycemia Caused by Insulinomas Related to Multiple Endocrine Neoplasia Type 1
Q46642648Imaging diagnostic standard in multiple endocrine neoplasia (MEN).
Q43066318Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies
Q71739940Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I
Q47594831Impact of "Tailored" Parathyroidectomy for Treatment of Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1.
Q66064017Impact of Exposure to Images of the Idealised Physique on Body Satisfaction, Dieting Intentions and Mood in Men.
Q36419268Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.
Q44013251Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Q35868179Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Q42248203Importance of early diagnosis and follow-up in multiple endocrine neoplasia (MEN II B).
Q71739620Improved carrier testing for multiple endocrine neoplasia, type 1, using new microsatellite-type DNA markers
Q39891535Improvement in the care of multiple endocrine neoplasia type 1 through a regional multidisciplinary clinic
Q88363803In Response to the Article Entitled "Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1"
Q42357146In Vivo Confocal Microscopic Architecture of Corneal Nerves in a Case of Multiple Endocrine Neoplasia Type 2b.
Q35602890In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model
Q38356545Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage
Q71958667Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1
Q57815324Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide study
Q50575214Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study.
Q33702544Incidental Detection of Synchronous Medullary Thyroid Carcinoma with Bilateral Adrenal Pheochromocytoma on Iodine-123 Metaiodobenzylguanidine Scintigraphy, Leading to Diagnosis of Multiple Endocrine Neoplasia 2A
Q57212188Incidental angiofibromas prompt a diagnosis of multiple endocrine neoplasia type-1 (MEN-1)
Q89122943Incidental occurrence of metastatic medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 1 carrying germline MEN1 and somatic RET mutations
Q72219318Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor
Q42831245Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
Q64710306Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes
Q34396191Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome
Q72127431Insulin sensitivity and glycemic control before and after parathyroidectomy in a diabetic patient with familial multiple endocrine neoplasia type 1
Q42442483Insulinoma associated with a case of multiple endocrine neoplasia type I: Functional somatostatin receptors and abnormal glucose-induced insulin secretion
Q36535654Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach
Q39253203Insulinomas in MEN-I patients: early detection and treatment of insulinomas in patients with the multiple endocrine neoplasia syndrome type-I.
Q73794693Internally shortened menin protein as a consequence of alternative RNA splicing due to a germline deletion in the multiple endocrine neoplasia type 1 gene
Q64114447Intertumor heterogeneity in 60 pancreatic neuroendocrine tumors associated with multiple endocrine neoplasia type 1
Q48315006Intracranial ependymoma associated with multiple endocrine neoplasia type 1.
Q44490818Intractable pruritus associated with insulinoma in the absence of multiple endocrine neoplasia: a novel paraneoplastic phenomenon
Q92337051Intraoperative Autofluorescence Parathyroid Identification in Patients With Multiple Endocrine Neoplasia Type 1
Q42487338Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism
Q46754951Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B.
Q39168537Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1?
Q58409100Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome?
Q80104133Is total parathyroidectomy the treatment of choice for hyperparathyroidism in multiple endocrine neoplasia type 1?
Q82262997Ischemic stroke as the presenting symptom of primary hyperparathyroidism due to multiple endocrine neoplasia type 1
Q24319691Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN1)
Q33189562Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus
Q90669649La néoplasie endocrinienne multiple de type 1 : mise au point après le congrès de l’ENETS 2019: Multiple Endocrine Neoplasia Type 1: Development after the ENETS 2019 Congress
Q72254133Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome
Q50211120Laparoscopic Total Gastrectomy(LTG)in Patient with Multiple Gastric Neuroendocrine Tumor Related to Multiple Endocrine Neoplasia Type 1 - Two Case Reports
Q81481912Laparoscopic surgery in patients with sporadic and multiple insulinomas associated with multiple endocrine neoplasia type 1
Q88254342Laparoscopic total pancreatectomy for multiple endocrine neoplasia type 1 syndrome-associated multifocal, non-functioning pancreatic neuroendocrine tumor: A case report
Q73535644Large and asymptomatic pancreatic islet cell tumor in a patient with multiple endocrine neoplasia type 1
Q35130166Laryngeal solitary multiple mucosal neuromas without multiple endocrine neoplasia (MEN) type 2B
Q50987648Late diagnosis of type 2B multiple endocrine neoplasia (MEN 2B) in a 23 year-old patient.
Q47352129Latent familial multiple endocrine neoplasia in Tasmania
Q36179244Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes.
Q74580275Lethality of multiple endocrine neoplasia type I
Q50023517Letter to the editors regarding: genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: a 23-year experience at a single institution
Q67514388Life saving glance diagnosis in type IIb multiple endocrine neoplasia
Q42807075Ligand stimulation of a Ret chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2B.
Q53287210Limited Parathyroidectomy in Multiple Endocrine Neoplasia Type 1-Associated Primary Hyperparathyroidism: A Setup for Failure.
Q52953312Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.
Q52078584Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.
Q74599340Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization?
Q69896216Linear cutaneous neuromas (dermatoneurie en stries): a limited phakomatosis with striated pigmentation corresponding to cutaneous hyperneury (featuring multiple endocrine neoplasia syndrome?)
Q72226145Linkage analysis of 7 polymorphic markers at chromosome 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families
Q69369483Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11
Q72555153Linkage and chromosome study of multiple endocrine neoplasia IIa
Q60021579Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1)
Q43742561Linked markers flanking the gene for multiple endocrine neoplasia type 2A.
Q73253136Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course?
Q40245197Living with multiple endocrine neoplasia type 1: decent care-insufficient medical and genetic information: a qualitative study of MEN 1 patients in a Swedish hospital
Q40624222Localization and identification of the multiple endocrine neoplasia type 1 disease gene.
Q35248378Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11.
Q73352853Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis
Q42474146Long term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa.
Q42945956Long-Term Suppressive Effect of Octreotide on Progression of Metastatic Gastrinoma with Multiple Endocrine Neoplasia Type 1: Seven-Year Follow up
Q38945777Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism?
Q73793369Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential?
Q35636304Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman
Q44184251Long-term follow-up of a kindred with multiple endocrine neoplasia type IIA.
Q42453655Long-term follow-up of a large North American kindred with multiple endocrine neoplasia type 2A
Q60334118Long-term follow-up of an 8-year-old boy with insulinoma as the first manifestation of a familial form of multiple endocrine neoplasia type 1
Q48383339Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome
Q43712224Long-term follow-up of patients with multiple endocrine neoplasia type 1.
Q48961547Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours
Q35029997Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1.
Q64151856Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
Q73320115Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1
Q38468233Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
Q41175153Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1.
Q42467034Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.
Q69369400Loss of the same alleles of HRAS1 and D11S151 in two independent pancreatic cancers from a patient with multiple endocrine neoplasia type 1
Q73225397Loss of wild-type MEN1 gene expression in multiple endocrine neoplasia type 1-associated parathyroid adenoma
Q63830013Low Carb Diets & Exercise for Cardiovascular Disease (CVD) Reduction
Q47751377Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients
Q37569272Lung adenocarcinoma and adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1.
Q42436998Lymph node gastrinoma in multiple endocrine neoplasia type 1 - a diagnostic challenge
Q39192564MEA (multiple endocrine adenomatosis) syndrome
Q97597895MEN 2A syndrome - Multiple endocrine neoplasia with autosomal dominant transmission
Q80068805MEN1 935-1G>C splicing mutation in an Indian patient with multiple endocrine neoplasia type 1
Q40663667MEN1 c.825‑1G>A mutation in a family with multiple endocrine neoplasia type 1: A case report
Q73422951MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1
Q81481297MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1
Q80112563MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1
Q35895475MENX and MEN4
Q64901491MON-321 Metastatic Melanoma with Unknown Primary Site in a Patient with Multiple Endocrine Neoplasia Type 1.
Q64911662MON-335 Phenocopy of Multiple Endocrine Neoplasia Type 1 (MEN1) Due to a Germline Cell Division Cycle 73 (CDC73) Variant.
Q64902329MON-531 Pattern of Health-Related Quality of Life Six Months after Parathyroidectomy in Patients with Multiple Endocrine Neoplasia Type 1 and Main Modifying Factors.
Q28083817MULTIPLE ENDOCRINE NEOPLASIA TYPE I and MEN II
Q91800576Magnetic Resonance Imaging or Endoscopic Ultrasonography for Detection and Surveillance of Pancreatic Neuroendocrine Neoplasms in Patients with Multiple Endocrine Neoplasia Type 1?
Q54233608Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1.
Q64658405Maintenance of Muscle Mass in Older People: the Negative Impact of Statin Therapy
Q69886890Malignant melanoma in multiple endocrine neoplasia
Q53437500Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma.
Q35835530Malignant nonfunctioning pheochromocytoma occurring in a mixed multiple endocrine neoplasia syndrome
Q35835473Malignant thymic carcinoid in multiple endocrine neoplasia type I syndrome: case report and literature review
Q43917974Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1.
Q74465461Management issues in the multiple endocrine neoplasia syndromes
Q39282940Management of a multiple endocrine neoplasia type 1 during pregnancy: A case report and review of the literature
Q40624202Management of hyperparathyroidism in the multiple endocrine neoplasia syndromes and other familial endocrinopathies.
Q51618363Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study.
Q46958734Management of nonfunctioning pancreatic endocrine tumors in the context of multiple endocrine neoplasia type 1 syndrome.
Q83300174Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1
Q77292874Management of pancreatic endocrine tumors in patients with multiple endocrine neoplasia type 1
Q41485460Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1.
Q36972533Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas
Q74817189Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1
Q39460993Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type I.
Q71739592Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: identification of a new distal recombinant
Q28247390Mapping of the gene encoding the B56 beta subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1)
Q58862325Mapping of the gene for multiple endocrine neoplasia type I to chromosome 11q13
Q67440889Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II
Q36550021Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations
Q36615929Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Q81975352Mediastinal seminoma in a patient with multiple endocrine neoplasia type 1
Q55502015Medical genetics: advances in brief: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
Q47409085Medical genetics: advances in brief: Parent-of-origin effects in multiple endocrine neoplasia type 2B.
Q71054366Medullary carcinoma of the thyroid and multiple endocrine neoplasia type II-B (author's transl)
Q72766171Medullary carcinoma of the thyroid gland with sustentacular cell-like cells in a patient with multiple endocrine neoplasia, type IIA. Report of a case with ultrastructural and immunohistochemical studies
Q70931730Medullary carcinoma of the thyroid in the multiple endocrine neoplasia IIA syndrome
Q35176452Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Q43352047Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report
Q42517738Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
Q72868793Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B
Q41551221Medullary thyroid carcinoma: one component of the inherited disorder multiple endocrine neoplasia type 2A.
Q83099032Melanocytic bronchopulmonary carcinoid tumor in a patient with multiple endocrine neoplasia syndrome type 1: a case report with emphasis on intraoperative cytological findings
Q35006210Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1.
Q35663471Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway
Q74071090Menin mutations in patients with multiple endocrine neoplasia type 1
Q47923900Menin mutations in the diagnosis and prediction of multiple endocrine neoplasia type 1.
Q24291124Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23
Q28216208Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23
Q40086069Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.
Q33661322Menin/PRMT5/hedgehog signaling: a potential target for the treatment of multiple endocrine neoplasia type 1 tumors
Q51051595Meningiomas may be a component tumor of multiple endocrine neoplasia type 1.
Q64789637Metabolic Availability of Methionine From Chickpeas in Adult Men
Q66047019Metabolic Availability of Metionine From Lentils in Adult Men
Q38273824Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Q79965804Metastasis of carcinoid to the arch of the axis in a multiple endocrine neoplasia patient: a case report
Q39516466Metastatic Pheochromocytoma Associated With Multiple Endocrine Neoplasia Syndrome Type II
Q90754275Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne)
Q37763678Metastatic alveolar rhabdomyosarcoma in multiple endocrine neoplasia type 2A.
Q89953657Metastatic multiple endocrine neoplasia type 1: report of one case
Q79483085Metastatic prolactinoma presenting as a cervical spinal cord tumour in multiple endocrine neoplasia type one (MEN-1)
Q35856545Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.
Q30815312Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome
Q64716399Microsurgical Varicocelectomy Versus No Surgery in Men With a Palpable Varicocele and an Abnormal Semen Analysis
Q39937444Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1.
Q35970538Minimally invasive parathyroid surgery for recurrent intrathyroid multiple endocrine neoplasia (MEN).
Q45150351Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism
Q69919207Mitogenic activity on parathyroid cells in plasma from members of a large kindred with multiple endocrine neoplasia type 1
Q72863131Mixed multiple endocrine neoplasia syndromes
Q72587872Mixed type Zollinger-Ellison syndrome in a florid case of multiple endocrine neoplasia type I. A case report
Q64222568Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men
Q54794427Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10.
Q38481638Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens
Q40624196Molecular abnormalities in tumors associated with multiple endocrine neoplasia type 2.
Q42520855Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
Q34386633Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.
Q35589304Molecular diagnosis of multiple endocrine neoplasia Type 2.
Q30317941Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium
Q67889192Molecular genetic mapping of the multiple endocrine neoplasia type 1 locus
Q60021532Molecular genetics and patient management of multiple endocrine neoplasia type 1
Q36111935Molecular genetics of multiple endocrine neoplasia types 1 and 2.
Q79354839Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2
Q52001742Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2B.
Q42827781Molecular mechanisms of development of multiple endocrine neoplasia 2 by RET mutations
Q40624165Molecular mechanisms of neoplasia in multiple endocrine neoplasia type 1-related and sporadic tumors of the pancreatic islet cells.
Q33807020Molecular pathology of multiple endocrine neoplasia type I: two novel germline mutations and updated classification of mutations affecting MEN1 gene.
Q57423384Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1
Q73417140Monosomy of chromosome 11 in pituitary adenoma in a patient with familial multiple endocrine neoplasia type 1
Q72398842Morphological and immunocytochemical studies of pancreatic multiple endocrine neoplasia type-1
Q64680260Motiv82Change: an HIV Prevention Study for Young Latino Men
Q41068030Mucosal neuroma, pheochromocytoma and medullary thyroid carcinoma: multiple endocrine neoplasia type 3
Q61811432Multimodality appearance of multiple endocrine neoplasia type 1: A case report
Q39119878Multiple Endocrine Adenomatosis of Mixed Type
Q39186116Multiple Endocrine Adenomatosis: in Support of the Common Origin Theories
Q63405774Multiple Endocrine Neoplasia 1: Providing Care for the Family
Q63405772Multiple Endocrine Neoplasia 2: Providing Care for the Family
Q56211629Multiple Endocrine Neoplasia Syndromes
Q62978461Multiple Endocrine Neoplasia Syndromes
Q86624384Multiple Endocrine Neoplasia Syndromes
Q55712143Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.
Q38827709Multiple Endocrine Neoplasia Syndromes: A Comprehensive Imaging Review
Q57793832Multiple Endocrine Neoplasia Type 1
Q60021128Multiple Endocrine Neoplasia Type 1
Q60021424Multiple Endocrine Neoplasia Type 1
Q94995161Multiple Endocrine Neoplasia Type 1
Q95467011Multiple Endocrine Neoplasia Type 1
Q95400369Multiple Endocrine Neoplasia Type 1 (MEN I, Wermer Syndrome)
Q101323230Multiple Endocrine Neoplasia Type 1 (MEN1) Phenocopy Due to a Cell Cycle Division 73 (CDC73) Variant
Q95435654Multiple Endocrine Neoplasia Type 1 (MEN1) Syndrome
Q99708563Multiple Endocrine Neoplasia Type 1 (MEN1) and the Pancreas - Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement
Q91531969Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis
Q36859779Multiple Endocrine Neoplasia Type 1 Presenting as Hypoglycemia due to Insulinoma
Q92033949Multiple Endocrine Neoplasia Type 1-Related Acute Pancreatitis
Q42464524Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*
Q91787051Multiple Endocrine Neoplasia Type 1: A Case Report With Review of Imaging Findings
Q103045698Multiple Endocrine Neoplasia Type 1: Latest Insights
Q100691335Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome
Q61795750Multiple Endocrine Neoplasia Type 2B
Q94586121Multiple Endocrine Neoplasia Type 4: Novel CDNK1B variant and immune anomalies
Q68321668Multiple Endocrine Neoplasia Type III
Q36525233Multiple Endocrine Neoplasia Type III: Case Report and Review
Q41591754Multiple Endocrine Neoplasia Type IIb: The Most Aggressive Form of Medullary Thyroid Carcinoma
Q57600501Multiple Endocrine Neoplasia Type-I-like Syndrome in Two Cats
Q39412594Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood
Q88866449Multiple Endocrine Neoplasia in Children and the Importance of Screening: Part 1
Q90286377Multiple Endocrine Neoplasia in Children and the Importance of Screening: Part 2
Q102068595Multiple Endocrine Neoplasia or Accidental Association?
Q80630867Multiple Endocrine Neoplasia type 1
Q38627799Multiple Endocrine Neoplasia, Type 1: Imaging Solutions to Clinical Questions
Q72890667Multiple Endocrine Neoplasia, Type II (MEN II)
Q38951675Multiple Endocrine Neoplasia: A Genetically Diverse Group of Familial Tumor Syndromes
Q36063577Multiple Endocrine Neoplasia: Genetics and Clinical Management
Q98208127Multiple Endocrine Neoplasia: Spectrum of Abdominal Manifestations
Q104582077Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?
Q52740193Multiple Neuroendocrine Tumors in Stomach and Duodenum in a Multiple Endocrine Neoplasia Type 1 Patient.
Q96640826Multiple Uterine Leiomyomas in Multiple Endocrine Neoplasia Type 1 with a Novel MEN1 Gene Mutation
Q45013500Multiple cutaneous collagenomas in the setting of multiple endocrine neoplasia type 1.
Q36714712Multiple endocrine adenomatosis (Type I) and familial hyperparathyroidism
Q72430550Multiple endocrine adenomatosis (type 1) --a case study
Q39402038Multiple endocrine adenomatosis and peptic ulcer
Q69888084Multiple endocrine adenomatosis manifested chiefly by hyperparathyroidism
Q44640740Multiple endocrine adenomatosis of multiple type I: comments based on a personal observation
Q54175202Multiple endocrine adenomatosis presenting as Cushing's syndrome and concurrent hyperparathyroidism with massive gastric hemorrhage. (Case report with ACTH, parathyroid hormone, and gastrin assays).
Q70056875Multiple endocrine adenomatosis presenting as Zollinger-Ellison syndrome, nonbeta islet cell adenoma, parathyroid adenoma, renal calculi, bronchial carcinoid, insulinoma, hepatic hamartoma, etc
Q39079714Multiple endocrine adenomatosis syndromes
Q68157307Multiple endocrine adenomatosis type I in pregnancy
Q72516167Multiple endocrine adenomatosis type I. Occurrence in an octogenarian with high levels of circulating pancreatic polypeptide
Q33824775Multiple endocrine adenomatosis type II (Sipple's syndrome) in twins
Q37783162Multiple endocrine adenomatosis type IIB. Report of two cases and review of the literature
Q70929086Multiple endocrine adenomatosis type IIb
Q40348860Multiple endocrine adenomatosis type IIb. Diagnosis and treatment
Q72496065Multiple endocrine adenomatosis with Cushing's disease and the amenorrhea-galactorrhea syndrome responsive to proton beam irradiation
Q71075225Multiple endocrine adenomatosis with metabolic myopathy
Q39213202Multiple endocrine adenomatosis, type 1
Q43801509Multiple endocrine neoplasia (M.E.N.) type II--case report
Q71426992Multiple endocrine neoplasia (MEN IIB) with Cushing's syndrome due to medullary thyroid carcinoma producing corticotropin-releasing hormone
Q72542985Multiple endocrine neoplasia (MEN) syndrome type IIB: gastrointestinal manifestations
Q38220432Multiple endocrine neoplasia (MEN) syndromes
Q39435988Multiple endocrine neoplasia (MEN) syndromes: cellular origins and interrelationships
Q45190440Multiple endocrine neoplasia (MEN) type II b: report of a case observed at autopsy with immunohistochemical study of mucosal neuromas.
Q69897701Multiple endocrine neoplasia (MEN)--Wermer and Sipple syndrome
Q34155265Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus
Q35743380Multiple endocrine neoplasia (MEN)-associated tumours
Q39209291Multiple endocrine neoplasia (type I)
Q67380143Multiple endocrine neoplasia (type II)
Q72555750Multiple endocrine neoplasia (type III). A retrospective family history
Q74302753Multiple endocrine neoplasia 1 gene alterations in MEN1-associated and sporadic lipomas
Q74383253Multiple endocrine neoplasia 1--current recommendations for diagnosis and treatment
Q40504497Multiple endocrine neoplasia 2 (MEN 2)/MEN 2A (Sipple syndrome).
Q49356194Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect
Q49889147Multiple endocrine neoplasia 2A (MEN 2A) syndrome
Q58665555Multiple endocrine neoplasia 2A and pregnancy: a medical and ethical challenge
Q46846758Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma
Q45180092Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess
Q74202701Multiple endocrine neoplasia 2A syndrome: Surgical management
Q40504503Multiple endocrine neoplasia 2B (MEN 2B)/MEN 3.
Q83912480Multiple endocrine neoplasia 2B presenting with pseudo-Hirschsprung's disease
Q30320428Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease
Q53956675Multiple endocrine neoplasia 2B with glaucoma associated with codon 918 mutation of the RET proto-oncogene.
Q41449967Multiple endocrine neoplasia 2B: Differential increase in enteric nerve subgroups in muscle and mucosa
Q41364430Multiple endocrine neoplasia 2B: delayed presentation, rapid diagnosis.
Q37957106Multiple endocrine neoplasia 2a presenting with pheochromocytoma and pituitary macroadenoma
Q72658148Multiple endocrine neoplasia 2a syndrome with multiple artery stenoses
Q44057063Multiple endocrine neoplasia II A syndrome: relationship between age of the patient, levels of basal calcitonin and size of the thyroid tumor
Q69896334Multiple endocrine neoplasia IIA found at autopsy
Q45048569Multiple endocrine neoplasia IIb: an unusual cause of chronic constipation
Q72538919Multiple endocrine neoplasia Type 1
Q82949836Multiple endocrine neoplasia [corrected] syndrome type 2B in early childhood: long-term benefit of prophylactic thyroidectomy
Q84917074Multiple endocrine neoplasia and different multiple pancreatic neuroendocrine tumors: is there any relation?
Q80336866Multiple endocrine neoplasia and polyglandular autoimmune syndrome: a new association
Q41773281Multiple endocrine neoplasia and primary hyperparathyroidism - practical approach
Q34995591Multiple endocrine neoplasia associated with von Recklinghausen's disease
Q55463834Multiple endocrine neoplasia associated with von Recklinghausen's disease.
Q72562319Multiple endocrine neoplasia excluding MEN type I, IIa and IIb
Q70402690Multiple endocrine neoplasia in a dog
Q73080550Multiple endocrine neoplasia in a dog
Q95421896Multiple endocrine neoplasia in an orthodontic patient: Interprofessional diagnostic and treatment implications
Q33570976Multiple endocrine neoplasia induced by the promiscuous expression of a viral oncogene
Q71441950Multiple endocrine neoplasia involving steroid producing glands
Q67326515Multiple endocrine neoplasia of the 2B type
Q73546345Multiple endocrine neoplasia of the first type (Wermer's syndrome)
Q37319319Multiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3.
Q72666135Multiple endocrine neoplasia presenting as phaeochromocytoma during pregnancy
Q72060463Multiple endocrine neoplasia presenting as primary amenorrhea: A case report
Q37393632Multiple endocrine neoplasia similar to human subtype 2A in a dog: Medullary thyroid carcinoma, bilateral pheochromocytoma and parathyroid adenoma
Q77482616Multiple endocrine neoplasia syndrome
Q71397257Multiple endocrine neoplasia syndrome type 1 presenting with hip fracture: a case report
Q31157584Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database
Q62978432Multiple endocrine neoplasia syndrome type 2: The value of screening and central registration
Q72550391Multiple endocrine neoplasia syndrome type I - familial occurrence
Q41748505Multiple endocrine neoplasia syndrome type IIb: a case report
Q74515599Multiple endocrine neoplasia syndrome, type 2B
Q40981105Multiple endocrine neoplasia syndrome, type III: review and case report
Q35257088Multiple endocrine neoplasia syndrome--type 2b. Case report and review
Q35988655Multiple endocrine neoplasia syndrome: genetic basis for clinical management
Q34108187Multiple endocrine neoplasia syndromes
Q62978448Multiple endocrine neoplasia syndromes
Q74383233Multiple endocrine neoplasia syndromes
Q80444208Multiple endocrine neoplasia syndromes
Q86544391Multiple endocrine neoplasia syndromes
Q38411934Multiple endocrine neoplasia syndromes 1 and 2: manifestations and management in childhood and adolescence
Q38117023Multiple endocrine neoplasia syndromes associated with mutation of p27.
Q40522630Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic, and molecular features.
Q37118544Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.
Q49295916Multiple endocrine neoplasia syndroms. Type 1
Q58862032Multiple endocrine neoplasia type 1
Q72143709Multiple endocrine neoplasia type 1
Q73083013Multiple endocrine neoplasia type 1
Q73210756Multiple endocrine neoplasia type 1
Q77164497Multiple endocrine neoplasia type 1
Q81416954Multiple endocrine neoplasia type 1
Q86555949Multiple endocrine neoplasia type 1
Q86736236Multiple endocrine neoplasia type 1
Q91713028Multiple endocrine neoplasia type 1
Q51493178Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.
Q40471503Multiple endocrine neoplasia type 1 (MEN 1) revisited
Q38355277Multiple endocrine neoplasia type 1 (MEN-1). Clinical, biochemical and genetical investigations
Q28293012Multiple endocrine neoplasia type 1 (MEN1)
Q98384186Multiple endocrine neoplasia type 1 (MEN1) 5' UTR deletion, in MEN1 family, decreases menin expression
Q28296266Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
Q54471962Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
Q57149325Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism
Q50760845Multiple endocrine neoplasia type 1 (MEN1) in Austria.
Q57423388Multiple endocrine neoplasia type 1 (MEN1) in two Asian families
Q100504482Multiple endocrine neoplasia type 1 (MEN1) presenting with renal stones: Case report and review
Q38070923Multiple endocrine neoplasia type 1 (MEN1).
Q40515711Multiple endocrine neoplasia type 1 (MEN1).
Q38696748Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years.
Q47689070Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases
Q28249576Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
Q78092007Multiple endocrine neoplasia type 1 (MEN1): clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop)
Q53860437Multiple endocrine neoplasia type 1 (MEN1): genetic and clinical analysis in the Southern Chinese.
Q81616168Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome
Q79441763Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas
Q37630910Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors
Q74025174Multiple endocrine neoplasia type 1 (MEN1): recent advances
Q71578501Multiple endocrine neoplasia type 1 accompanied by duodenal carcinoid tumors and hypergastrinemia: a familial case
Q41136536Multiple endocrine neoplasia type 1 and 2: from morphology to molecular pathology 1997.
Q35640833Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
Q41778591Multiple endocrine neoplasia type 1 and adrenal Cushing's
Q44146311Multiple endocrine neoplasia type 1 and adrenal lesions
Q89129441Multiple endocrine neoplasia type 1 and breast cancer. An association to consider
Q41485423Multiple endocrine neoplasia type 1 and the search for the genetic trigger.
Q52890745Multiple endocrine neoplasia type 1 associated with a new germline Men1 mutation in a family with atypical tumor phenotype.
Q57111924Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor
Q33778307Multiple endocrine neoplasia type 1 associated with breast cancer: A case report and review of the literature
Q44620809Multiple endocrine neoplasia type 1 associated with malignant lymphoma and other complications
Q41063144Multiple endocrine neoplasia type 1 associated with spinal ependymoma
Q77765509Multiple endocrine neoplasia type 1 concomitant with Prader-Willi syndrome: case report and genetic diagnosis
Q34132545Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice
Q73816222Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors
Q48100816Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Q81828264Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan
Q81398600Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile
Q72056442Multiple endocrine neoplasia type 1 in France: clinical and genetic studies
Q43840894Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database
Q80981325Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation
Q91629346Multiple endocrine neoplasia type 1 in Poland: a two-centre experience
Q73507307Multiple endocrine neoplasia type 1 in a crossbred dog
Q45201520Multiple endocrine neoplasia type 1 in end-stage renal failure
Q98206371Multiple endocrine neoplasia type 1 in patients with gastroenteropancreatic neuroendocrine tumors: An opportunity for early diagnosis and appropriate management
Q60455214Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types
Q24301482Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response
Q50631669Multiple endocrine neoplasia type 1 is not rare in Japan.
Q35631212Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia
Q44976623Multiple endocrine neoplasia type 1 manifesting with chronic and persistent diarrhea
Q80874213Multiple endocrine neoplasia type 1 parathyroid adenoma development over time
Q77222763Multiple endocrine neoplasia type 1 polymorphism D418D is associated with sporadic primary hyperparathyroidism
Q74073443Multiple endocrine neoplasia type 1 presented with manic-depressive disorder: a case report with an identified MEN1 gene mutation
Q70885070Multiple endocrine neoplasia type 1 presenting as insulinoma, gastrinoma, and postbulbar duodenal ulcers: report of a case
Q81595754Multiple endocrine neoplasia type 1 presenting as psychosis
Q82789286Multiple endocrine neoplasia type 1 presenting as refractory epilepsy and polyneuropathy--a case report
Q71401807Multiple endocrine neoplasia type 1 presenting as rosacea
Q58798854Multiple endocrine neoplasia type 1 presenting with concurrent insulinoma and prolactinoma in early-adolescence
Q48380415Multiple endocrine neoplasia type 1 presenting with refractory seizures.
Q97529409Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture
Q84441029Multiple endocrine neoplasia type 1 simultaneous with various types of enteropancreatic endocrine tumors: one case report: lessons learned
Q52984755Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
Q44364486Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma
Q37453340Multiple endocrine neoplasia type 1 with anterior mediastinal parathyroid adenoma: successful localization using Tc-99m sestamibi SPECT/CT.
Q53037524Multiple endocrine neoplasia type 1 with gastric neuroendocrine tumor presented with gastric polyposis.
Q37040923Multiple endocrine neoplasia type 1 with multiple leiomyomas linked to a novel mutation in the MEN1 gene
Q53674213Multiple endocrine neoplasia type 1 with pyonephrosis.
Q44788859Multiple endocrine neoplasia type 1 with unusual concomitance of various neoplastic disorders
Q38088573Multiple endocrine neoplasia type 1 with upper gastrointestinal hemorrhage and perforation: a case report and review
Q36739108Multiple endocrine neoplasia type 1- presenting multiple lipomas and hypoglycemia onset
Q33503348Multiple endocrine neoplasia type 1--presenting with impotence.
Q43093709Multiple endocrine neoplasia type 1-associated cystic pancreatic endocrine neoplasia and multifocal cholesterol granulomas
Q57186199Multiple endocrine neoplasia type 1-associated thyrotropin-producing pituitary carcinoma: report of a probable de novo example
Q33871564Multiple endocrine neoplasia type 1.
Q40624158Multiple endocrine neoplasia type 1. Clinical features and screening
Q36673857Multiple endocrine neoplasia type 1. Digestive hormones in the screening
Q49212579Multiple endocrine neoplasia type 1. Surgical therapy of primary hyperparathyroidism
Q37517691Multiple endocrine neoplasia type 1: a chromatin writer's block.
Q71666979Multiple endocrine neoplasia type 1: an interesting Canadian pedigree
Q56927393Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database
Q38527323Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors
Q33766915Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
Q33798718Multiple endocrine neoplasia type 1: clinical and genetic features.
Q77292736Multiple endocrine neoplasia type 1: clinical and genetic topics
Q91163366Multiple endocrine neoplasia type 1: clinical correlates of MEN1 gene methylation
Q37643633Multiple endocrine neoplasia type 1: clinical manifestations and management
Q33693358Multiple endocrine neoplasia type 1: current concepts in diagnosis and management.
Q35208527Multiple endocrine neoplasia type 1: duodenopancreatic tumors.
Q47901554Multiple endocrine neoplasia type 1: duodenopancreatic tumours.
Q59340502Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients
Q34924827Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance
Q34053332Multiple endocrine neoplasia type 1: from bedside to benchside
Q28211534Multiple endocrine neoplasia type 1: new clinical and basic findings
Q77799614Multiple endocrine neoplasia type 1: scintigraphic and magnetic resonance demonstration
Q74171259Multiple endocrine neoplasia type 1: usefulness of genetic tests in atypical cases
Q28214101Multiple endocrine neoplasia type 1Burin from Mauritius: a novel MEN1 mutation
Q68085045Multiple endocrine neoplasia type 2
Q72143711Multiple endocrine neoplasia type 2
Q72201403Multiple endocrine neoplasia type 2
Q80282005Multiple endocrine neoplasia type 2
Q85016290Multiple endocrine neoplasia type 2
Q86736245Multiple endocrine neoplasia type 2
Q91424004Multiple endocrine neoplasia type 2
Q77297258Multiple endocrine neoplasia type 2-associated RET proto-oncogene mutations do not contribute to the pathogenesis of sporadic parathyroid tumors
Q34557491Multiple endocrine neoplasia type 2.
Q40624174Multiple endocrine neoplasia type 2. Clinical features and screening.
Q69375324Multiple endocrine neoplasia type 2. International symposium. Heidelberg, November 5-7, 1987
Q43430037Multiple endocrine neoplasia type 2A
Q84222230Multiple endocrine neoplasia type 2A
Q45078161Multiple endocrine neoplasia type 2A.
Q33872250Multiple endocrine neoplasia type 2A. Study of a family.
Q46795959Multiple endocrine neoplasia type 2A/localized cutaneous lichen amyloidosis associated with malignant pheochromocytoma and ganglioneuroma
Q74152746Multiple endocrine neoplasia type 2B
Q34253160Multiple endocrine neoplasia type 2B--genetic basis and clinical expression
Q35083989Multiple endocrine neoplasia type 2B. A case report and review of the syndrome.
Q68162846Multiple endocrine neoplasia type 3: three cases with mucosal neuromata
Q38104963Multiple endocrine neoplasia type 4.
Q69863419Multiple endocrine neoplasia type I
Q69869472Multiple endocrine neoplasia type I
Q72329985Multiple endocrine neoplasia type I
Q44756081Multiple endocrine neoplasia type I (MEN I). A wide range of clinical presentation. Report of three cases
Q46949839Multiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid
Q80363894Multiple endocrine neoplasia type I in a cat
Q43666316Multiple endocrine neoplasia type I presenting as recurrent stroke like episodes.
Q47868111Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue?
Q44038591Multiple endocrine neoplasia type I with Cushing's disease, primary hyperparathyroidism, and insulin-glucagonoma
Q72545363Multiple endocrine neoplasia type I--Zollinger-Ellison syndrome and hyperparathyroidism
Q34696380Multiple endocrine neoplasia type I.
Q69875684Multiple endocrine neoplasia type I. A case report
Q41515505Multiple endocrine neoplasia type I. Clinical genetics and diagnosis
Q41515514Multiple endocrine neoplasia type I. Surgical therapy
Q46416674Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred.
Q40375094Multiple endocrine neoplasia type I: clinical syndrome to molecular genetics
Q36496864Multiple endocrine neoplasia type I: general features and new insights into etiology
Q40553153Multiple endocrine neoplasia type II
Q68082769Multiple endocrine neoplasia type II B with symptoms suggesting Hirschsprung's disease: a case report
Q41515521Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Impact of genetic screening on management.
Q69371148Multiple endocrine neoplasia type II with Zollinger-Ellison syndrome caused by a solitary pancreatic gastrinoma
Q71054369Multiple endocrine neoplasia type II-B (author's transl)
Q41953939Multiple endocrine neoplasia type II.
Q44361876Multiple endocrine neoplasia type II: clinical, biological and epidemiological features. French Medullary Study Group
Q72585610Multiple endocrine neoplasia type II: the role of gastrointestinal humoral factors in calcitonin release following alcohol and pentagastrin stimulation
Q64980338Multiple endocrine neoplasia type IIA (Sipple's syndrome) presenting in pregnancy.
Q70929077Multiple endocrine neoplasia type IIB
Q68084872Multiple endocrine neoplasia type IIB identified by magnetic resonance imaging
Q41766897Multiple endocrine neoplasia type IIB.
Q88053870Multiple endocrine neoplasia type IIa associated with Cushing's syndrome
Q77514989Multiple endocrine neoplasia type IIa: a case report
Q69918474Multiple endocrine neoplasia type IIb--a case report
Q44298434Multiple endocrine neoplasia type IIb.
Q72678178Multiple endocrine neoplasia type IIb. Report of a case
Q72691335Multiple endocrine neoplasia type IIb: a case report
Q46698116Multiple endocrine neoplasia type IIb: a clinicopathological report
Q39462421Multiple endocrine neoplasia type IIb: a description of several patients and review of the literature
Q43543456Multiple endocrine neoplasia type iia: report of a family with a study of three generations in qatar
Q78018181Multiple endocrine neoplasia type two B. A case report with light and electron microscopic and immunohistochemical correlation
Q42488214Multiple endocrine neoplasia type-1.
Q54733518Multiple endocrine neoplasia types 1 and 2.
Q69889578Multiple endocrine neoplasia with Cushing's syndrome due to paraganglioma producing corticotropin-releasing factor and adrenocorticotropin
Q55155700Multiple endocrine neoplasia with pulmonary localization: a new protocol of approach.
Q72457103Multiple endocrine neoplasia with skeletal manifestations
Q38058921Multiple endocrine neoplasia, the old and the new: a mini review
Q69902362Multiple endocrine neoplasia, type 1, with pancreatic cholera
Q39781002Multiple endocrine neoplasia, type 2b
Q40124465Multiple endocrine neoplasia, type I (MEN I)
Q52094174Multiple endocrine neoplasia, type I. Association with marfanoid habitus, optic atrophy, and other abnormalities.
Q35229504Multiple endocrine neoplasia, type II: a combined surgical and genetic approach to treatment
Q43051265Multiple endocrine neoplasia, type II: a combined surgical and genetic approach to treatment [correction]
Q69885887Multiple endocrine neoplasia, type III
Q42471136Multiple endocrine neoplasia, type IIb. Report of a case.
Q39307346Multiple endocrine neoplasia: Part I. Wermer's syndrome
Q44103520Multiple endocrine neoplasia: Part II. Sipple's syndrome
Q92454114Multiple endocrine neoplasia: an update
Q42952794Multiple endocrine neoplasia: genetic aspects
Q37606868Multiple endocrine neoplasia: how many syndromes?
Q82200021Multiple endocrine neoplasia: paediatric perspective
Q69881032Multiple endocrine neoplasia: search for the oncogenic trigger
Q36426445Multiple endocrine neoplasia: spectrum of radiologic appearances and discussion of a multitechnique imaging approach
Q87138899Multiple endocrine neoplasia: the enigma of MEN
Q73581048Multiple endocrine neoplasia: the paradigm of the arrival of molecular biology in clinical practice
Q37847873Multiple endocrine neoplasia: types 1 and 2.
Q73543135Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1
Q35746773Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1.
Q44809974Multiple mucosal neuroma (MMN) or multiple endocrine neoplasia (MEN) type 3 syndrome. Ocular manifestations: a case report
Q69929159Multiple nonfunctional pancreatic islet cell tumor in multiple endocrine neoplasia type I. A case report
Q40725016Multiple organ failure and coma as initial presentation of pheochromocytoma in a patient with multiple endocrine neoplasia (MEN) type II A.
Q57423374Mutation Analysis of the MEN1 Gene in Multiple Endocrine Neoplasia Type 1, Familial Acromegaly and Familial Isolated Hyperparathyroidism
Q43109376Mutation analysis in a Chinese family with multiple endocrine neoplasia type 1.
Q84295231Mutation analysis in two Chinese families with multiple endocrine neoplasia type 1
Q77794377Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases
Q58862086Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism
Q46763619Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up
Q74150791Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas
Q60021516Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions
Q41041236Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.
Q71070755Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group
Q33570313My, How Things Have Changed in Multiple Endocrine Neoplasia Type 2A!
Q41370173Myasthenia gravis and thymoma in multiple endocrine neoplasia (MEN-1) syndrome
Q45200677Myocardial calcinosis in a juvenile patient with Wermer syndrome (multiple endocrine neoplasia type I)
Q33630439Myotonic dystrophy and hyperparathyroidism: association with neurofibromatosis and multiple endocrine adenomatosis type 2A.
Q64046733Myths and facts...about multiple endocrine neoplasia type 1
Q35895509Narrowing the gap of personalized medicine in emerging countries: the case of multiple endocrine neoplasias in Brazil
Q44655527Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study
Q50794017Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
Q69909854Neuroendocrine (carcinoid) tumor of the lung and type I multiple endocrine neoplasia
Q47981710Neuroendocrine thymic carcinoma metastatic to the parathyroid gland that was reimplanted into the forearm in patient with multiple endocrine neoplasia type 1 syndrome: a challenging management dilemma
Q51629829Neurofibromatosis type 1: should we screen for other genetic syndromes? A case report of co-existence with multiple endocrine neoplasia 2A.
Q34967534Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells.
Q69892619Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma
Q35677681New insights in genetic testing of Multiple Endocrine Neoplasia type 1 (MEN1).
Q40654769No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Q58108250No evidence of adverse fertility and pregnancy outcomes in patients with unrecognised and untreated multiple endocrine neoplasia type 1
Q73564479No evidence of germline mutation or somatic deletion of the MEN1 gene in a case of familial multiple endocrine neoplasia type 1 (MEN1)
Q47724734Non-mammalian models of multiple endocrine neoplasia type 2.
Q49850788Nonfunctional pancreatic endocrine tumor in the peripancreatic region in a Chinese patient with multiple endocrine neoplasia type 1.
Q69886011Nonidentical expressions of multiple endocrine neoplasia, type I, in identical twins
Q42230741Not just skin deep: a case report of multiple endocrine neoplasia type 1.
Q53791929Notalgia Paresthetica and Multiple Endocrine Neoplasia Syndrome 2A: A Case Report.
Q80235721Novel 1113delC menin gene mutation in a Polish family with multiple endocrine neoplasia type 1 syndrome
Q98731881Novel Germline c.105_107dupGCT MEN1 Mutation in a Family with Newly Diagnosed Multiple Endocrine Neoplasia Type 1
Q47608497Novel Germline p.Gly42Val MEN1 Mutation in a Family with Multiple Endocrine Neoplasia Type 1 - Excellent Response of Prolactinoma to Cabergoline
Q77329624Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1
Q80445192Novel MEN1 germline mutations in Brazilian families with multiple endocrine neoplasia type 1
Q92023686Novel Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1
Q88230681Novel Somatic RET Mutation Questioning the Causality of the RET I852M Germline Sequence Variant in Multiple Endocrine Neoplasia 2A
Q38006832Novel association of thymic carcinoid with a germline mutation in a kindred with multiple endocrine neoplasia 1 (MEN1).
Q74181220Novel deletional mutation of the MEN 1 gene in a kindred with multiple endocrine neoplasia type 1
Q46543811Novel germline mutations of the MEN1 gene in Greek families with multiple endocrine neoplasia type 1.
Q77941044Novel germline mutations of the MEN1 gene in Japanese patients with multiple endocrine neoplasia type 1
Q37015563Novel multiple endocrine neoplasia type 1 variations in patients with sporadic primary hyperparathyroidism
Q44912147Novel mutation 928G>C of MEN1 gene in a familial multiple endocrine neoplasia type 1 case (MEN1) with co-existence of insulinoma and glucagonoma
Q82192110Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain
Q74546434Novel sequence variants of the genes associated with the multiple endocrine neoplasia syndromes 1 and 2. analysis by an "in silico approach.".
Q67526962Nuclear DNA analysis of hyperplastic parathyroid glands in multiple endocrine neoplasia type I
Q40965241Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin.
Q92338551Occult insulinoma, glucagonoma and pancreatic endocrine pseudotumour in a patient with multiple endocrine neoplasia type 1
Q73202362Octreotide improves biochemical, radiologic, and symptomatic indices of gastroenteropancreatic neoplasia in patients with multiple endocrine neoplasia type 1 (MEN-1). Implications for an integrated model of MEN-1 tumorigenesis
Q44027386Octreotide therapy in multiple endocrine neoplasia type-1
Q66032762Older Men and Testosterone
Q53673624Operation for insulinomas in multiple endocrine neoplasia type 1: When pancreatoduodenectomy is appropriate.
Q51065877Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism.
Q44554711Ophthalmic manifestations of multiple endocrine neoplasia, type three
Q100426015Optimal extent of initial parathyroid resection in patients with multiple endocrine neoplasia syndrome type 1: A meta-analysis
Q34410233Oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison
Q86568989Oral lipoma associated with multiple endocrine neoplasia (MEN) type 1
Q72009221Oral-facial manifestations of the multiple endocrine neoplasia syndrome
Q73086485Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy
Q93093647Outcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1
Q81573105Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1
Q73432218Ovarian gastrinoma in multiple endocrine neoplasia type I: a case report
Q34241873Ovarian strumal carcinoid in association with multiple endocrine neoplasia, type IIA
Q36214629PTCH 1 staining of pancreatic neuroendocrine tumor (PNET) samples from patients with and without multiple endocrine neoplasia (MEN-1) syndrome reveals a potential therapeutic target
Q92202007Paediatric and young adult manifestations and outcomes of multiple endocrine neoplasia type 1
Q49671127Painful Hips and a Nodular Neck: Bilateral Slipped Capital Femoral Epiphysis Leading to the Diagnosis of Multiple Endocrine Neoplasia: A Case Report.
Q46348851Pancreatectomy for multiple endocrine neoplasia with distant metastases and magistral arteries invasion
Q79775342Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias
Q57358435Pancreatic Anomaly With Multiple Endocrine Neoplasia Type 1
Q61884205Pancreatic Endocrine Tumor in Multiple Endocrine Neoplasia Type 1 Syndrome With Intraductal Growth Into the Main Pancreatic Duct
Q74453949Pancreatic Neuroendocrine Carcinoma Metastatic to the Breast as Part of the Multiple Endocrine Neoplasia Type 1 Syndrome
Q96680466Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences
Q42956856Pancreatic adenocarcinoma in a patient with multiple endocrine neoplasia 1 syndrome
Q28507607Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice
Q37873202Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature.
Q46251739Pancreatic endocrine tumors with loss of heterozygosity at the multiple endocrine neoplasia type I locus
Q69903855Pancreatic endocrine tumour producing growth hormone-releasing hormone associated with multiple endocrine neoplasia type I syndrome
Q54698872Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Q77687431Pancreatic islet cell tumor metastasis in multiple endocrine neoplasia type 1: correlation with primary tumor size
Q39230152Pancreatic islet cell tumors and their syndromes. II. Zollinger-Ellison syndrome, glucagonoma syndrome, multiple endocrine adenomatosis and islet cell tumors not obviously provable
Q41785102Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients
Q42449253Pancreatic polypeptide is a useful plasma marker for radiographically evident pancreatic islet cell tumors in patients with multiple endocrine neoplasia type 1.
Q67522369Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment
Q73292276Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance?
Q34929913Pancreatitis as the first manifestation of multiple endocrine neoplasia type 2A.
Q80155306Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life
Q36415051Papillary adenocarcinoma of the thyroid followed by manifestation of multiple endocrine neoplasia (MEN) type I: a retrospective study of patient's data in the past 11 years and histological studies of the thyroid, parathyroid, and pancreatic islet
Q41027067Papillary thyroid carcinoma and multiple endocrine neoplasia type 2.
Q42462607Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?
Q86399065Parasitic myomas after laparoscopic-assisted myomectomy in multiple endocrine neoplasia type 1
Q67886916Parathyroid carcinoma in a patient with non-secretory pituitary tumor: a variant of multiple endocrine neoplasia type-I?
Q80058442Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity
Q37505692Parathyroid carcinoma in multiple endocrine neoplasia type 1 with a classic germline mutation
Q37979132Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature
Q49963710Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case
Q41409004Parathyroid glands and the multiple endocrine neoplasia syndromes and familial hypocalciuric hypercalcemia
Q73837776Parathyroid hormone related protein (PTHrP) mediated hypercalcaemia complicating enteropancreatic malignancy in multiple endocrine neoplasia type 1 (MEN 1)
Q69893891Parathyroid hormone release in vitro in hyperparathyroidism associated with multiple endocrine neoplasia type 1
Q43448006Parathyroid hyperplasia in multiple endocrine neoplasia type 1: a pathological and immunohistochemical reappraisal
Q69881030Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1
Q56608651Parathyroid surgery in the multiple endocrine neoplasia type I syndrome: Choice of surgical procedure
Q79754606Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: unobserved multiple endocrine neoplasia as an explanation
Q41133584Parathyroid tumor biology in familial multiple endocrine neoplasia type 1: a model for cancer development
Q91536098Parental Multiple Endocrine Neoplasia Type 1 (MEN 1) Is Associated with Increased Offspring Childhood Mortality
Q57819914Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1
Q37066453Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model.
Q36911589Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression
Q42424883Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1.
Q40712327Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
Q45156830Pathological case of the month. Medullary thyroid carcinoma in multiple endocrine neoplasia type IIB
Q68091877Pathological features of multiple endocrine neoplasia type IIb in childhood
Q47726041Patient quality of life and prognosis in multiple endocrine neoplasia type 2.
Q42485752Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus
Q30317906Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening
Q69907900Pediatric implications of multiple endocrine neoplasia
Q73178229Pediatric medullary carcinoma of the thyroid with point mutation of RET proto-oncogene associated with multiple endocrine neoplasia and initially diagnosed by fine-needle aspiration biopsy
Q64659099Pelvic Floor Muscle Training(PFMT) on Lower Urinary Tract Symptoms (LUTS) in Men With Stroke
Q38157760Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
Q69371611Pentagastrin stimulation of calcitonin in pheochromocytoma does not always indicate multiple endocrine neoplasia type II
Q33702522Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE for Metastatic Neuroendocrine Tumor Occurring in Association with Multiple Endocrine Neoplasia Type 1 and Cushing's Syndrome
Q72538660Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I
Q46237327Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1.
Q39024069Perioperative Severe Hypotension in a Patient with Multiple Endocrine Neoplasia Type IIb and Bilateral Adrenalectomies: Time to Review the Evidence for Stress Dose Steroids
Q84596867Peripheral bone mineral density in correlation to disease-related predisposing conditions in patients with multiple endocrine neoplasia type 1
Q40826282Perivascular cells harboring multiple endocrine neoplasia type 1 alterations are neoplastic cells in angiofibromas.
Q74129471Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1)
Q72563065Phenotype mapping of the multiple endocrine neoplasia type II syndrome
Q57591002Pheochromocytoma and the Multiple Endocrine Neoplasia Syndromes
Q43876045Pheochromocytoma in a pregnant woman with multiple endocrine neoplasia type 2a.
Q69871232Pheochromocytoma in multiple endocrine neoplasia
Q72538322Pheochromocytoma in multiple endocrine neoplasia type II: an example of the two-hit theory of neoplasia
Q34276843Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma
Q44801201Pheochromocytoma multisystem crisis in a patient with multiple endocrine neoplasia type IIB and pyelonephritis
Q38614500Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.
Q74128567Picture of the month. Multiple endocrine neoplasia 2B syndrome
Q52985287Pituitary Prolactinoma Imaged by 99mTc-Sestamibi SPECT/CT in a Multiple Endocrine Neoplasia Type 1 Patient.
Q40213769Pituitary adenoma, primary parathyroid hyperplasia and papillary (non-medullary) thyroid carcinoma. A case of multiple endocrine neoplasia (MEN).
Q44354633Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1.
Q91022115Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China
Q91539457Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience
Q42543374Pituitary adenomas of the multiple endocrine neoplasia type I syndrome
Q40370359Pituitary lesions in multiple endocrine neoplasia syndrome (MENS) type 1.
Q52142743Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1.
Q70442336Pituitary prolactinoma, adrenal aldosterone-producing adenomas, gastric schwannoma and colonic polyadenomas: a possible variant of multiple endocrine neoplasia (MEN) type I
Q69811777Pituitary prolactinoma, pancreatic glucagonomas, and aldosterone-producing adrenal cortical adenoma: a suggested variant of multiple endocrine neoplasia type I
Q72539638Pituitary proliferative lesions in aging male Long-Evans rats. A model of mixed multiple endocrine neoplasia syndrome
Q80775138Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients
Q42476057Plasma chromogranin A in patients with multiple endocrine neoplasia type 1.
Q60455201Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1
Q77464610Pluripotent tumor cells in benign pituitary adenomas associated with multiple endocrine neoplasia type 1
Q66696845Polyendocrine adenomatosis or type 2b multiple endocrine neoplasia (author's transl)
Q70067004Positive correlation between urinary excretion of catecholamine metabolites and tumour mass in pheochromocytoma. Results in patients with sustained and paroxysmal hypertension and multiple endocrine neoplasia
Q83238694Possible association between Carney complex and multiple endocrine neoplasia type 1 phenotypes
Q57644097Potential variant of multiple endocrine neoplasia in a dog
Q65330539PowerUp for Health: A Diabetes Prevention Program for Men
Q67889197Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1
Q81735926Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas
Q51369055Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
Q77424594Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children
Q57423378Predictive diagnosis of multiple endocrine neoplasia (MEN 1) in four Australian kindreds
Q42504745Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families
Q35601230Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms
Q45106664Pregnancy complicated by multiple endocrine neoplasia type IIA (Sipple's syndrome).
Q37070365Pregnancy in multiple endocrine neoplasia type 1 equals multiple complications
Q49861512Pregnancy on vandetanib in metastatic medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2B.
Q54940947Preimplantation genetic diagnosis for a patient with multiple endocrine neoplasia type 1: case report.
Q36770359Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients
Q74626471Premature centromere division in patients with multiple endocrine neoplasia type 1
Q47869793Prenatal molecular diagnosis of RET proto-oncogene mutation in multiple endocrine neoplasia type 2A.
Q47179409Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.
Q51356001Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1.
Q42445792Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a
Q44774370Preoperative multiple endocrine neoplasia type 1 diagnosis improves the surgical outcomes of pediatric patients with primary hyperparathyroidism.
Q74006563Preoperative sestamibi scanning and surgical findings at bilateral, unilateral, or minimal reoperation for recurrent hyperparathyroidism after subtotal parathyroidectomy in patients with multiple endocrine neoplasia type 1
Q47699890Presence of the 918 mutation in the RET proto-oncogene in a Mexican patient with multiple endocrine neoplasia type 2B.
Q40999454Presence of the RET Cys634Tyr mutation and Gly691Ser functional polymorphism in Iranian families with multiple endocrine neoplasia type 2A.
Q92440132Present status of prophylactic thyroidectomy in pediatric multiple endocrine neoplasia 2: a nationwide survey in Japan 1997-2017
Q46191004Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome
Q42485080Presymptomatic screening for medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2A.
Q42020687Presymptomatic testing using DNA markers for individuals at risk for familial multiple endocrine neoplasia 2A.
Q42487300Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
Q28284546Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia
Q79334943Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours
Q38306859Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 - case report and review of the literature
Q77687401Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1
Q40591170Primary carcinoid of the prostate in conjunction with multiple endocrine neoplasia IIb in a child
Q72524807Primary hyperparathyroidism and multiple endocrine neoplasia (MEN)
Q69858364Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy
Q110661619Primary hyperparathyroidism in multiple endocrine neoplasia type 1 (MEN-1) according to the online russian registry
Q82083940Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates
Q71184093Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons
Q72550169Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes. Surgical experience
Q41781008Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1.
Q74482017Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas
Q67889199Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: experience by a single surgical team in Japan
Q53091466Primary hyperparathyroidism in young people. When should we perform genetic testing for multiple endocrine neoplasia 1 (MEN-1)?
Q39128687Primary uterine tumors and multiple endocrine adenomatosis, type I
Q74817169Proceedings of the 6th International Workshop on Multiple Endocrine Neoplasia and von Hippel-Lindau Disease. Noordwijkerhout, the Netherlands, 25-28 June 1997
Q102319006Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters
Q77917882Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE)
Q35879571Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
Q38623304Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group
Q39261218Prolactin-Secreting Pituitary Adenomas in Multiple Endocrine Adenomatosis, Type I
Q66969988Prolactin-secreting pituitary adenomas. Association with multiple endocrine neoplasia, type I
Q60021614Prolactinoma presenting in identical twins with multiple endocrine neoplasia type 1
Q71626575Prolactinoma presenting in identical twins with multiple endocrine neoplasia type 1
Q66696990Prolactinomas and the multiple endocrine adenomatosis type-1 complex
Q71070773Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance pattern
Q72442855Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors
Q35833141Proliferation of endothelial component of parathyroid gland in multiple endocrine neoplasia type 1. Potential relationship with a mitogenic factor.
Q35661980Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors
Q71184097Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated?
Q53692326Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2.
Q58121521Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort
Q43092451Prophylactic thyroidectomy in multiple endocrine neoplasia syndrome
Q42483973Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
Q35104972Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene.
Q42505458Prophylactic total thyroidectomy in an 8-year-old girl with multiple endocrine neoplasia type 2A.
Q38100765Prophylactic total thyroidectomy using the minimally invasive video-assisted approach in children with multiple endocrine neoplasia type 2.
Q42510774Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1.
Q82455992Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1
Q80938862Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1
Q42453717Prospective screening in multiple endocrine neoplasia type 1.
Q71568271Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1
Q77687426Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1
Q53657069Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.
Q65390573Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU)
Q88030045Prostate adenocarcinoma in a young patient with multiple endocrine neoplasia 2B
Q42504153Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.
Q95655080Pulmonary Function in Patients with Multiple Endocrine Neoplasia 2B (MEN2B)
Q73590876Pulmonary lymphangioleiomyoma in a patient with multiple endocrine neoplasia type I
Q38449326Pyrosequencing technology as a method for the diagnosis of multiple endocrine neoplasia type 2.
Q104755768Quality of life in Italian patients with Multiple endocrine neoplasia type 1 (MEN 1): results of an extensive survey
Q51016174Quality of life in patients with multiple endocrine neoplasia type 1 (MEN 1)
Q69881445Quantitative study of a proposed interstitial del (20p 12.2) in multiple endocrine neoplasia (MEN-II)
Q90675538Questions and Controversies About Parathyroid Pathophysiology in Children With Multiple Endocrine Neoplasia Type 1
Q58006266RET Mutation Screening in Familial Cutaneous Lichen Amyloidosis and in Skin Amyloidosis Associated With Multiple Endocrine Neoplasia
Q37760280RET codon 804 mutations in multiple endocrine neoplasia 2: genotype-phenotype correlations and implications in clinical management
Q21135360RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family
Q53340955RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B.
Q83665289RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2
Q54690116RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A.
Q80517527RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds
Q77735037RET protooncogene analysis in the diagnosis of medullary thyroid carcinoma and multiple endocrine neoplasia type II
Q41181202RET protooncogene mutational analysis in multiple endocrine neoplasia syndrome type 2B: case report and review of the literature
Q38298928RFLP analysis of human chromosome 11 region q13 in multiple symmetric lipomatosis and multiple endocrine neoplasia type 1-associated lipomas
Q63819035Radiological Biological Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
Q33656493Radiological surveillance in multiple endocrine neoplasia type 1: a double-edged sword?
Q38130273Rapid development of thymic neuroendocrine carcinoma despite transcervical thymectomy in a patient with multiple endocrine neoplasia type 1.
Q79450960Rapidly growing collagenomas in multiple endocrine neoplasia type I
Q37198026Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states
Q36897496Rare presentation of laryngeal neuroma in a patient with multiple endocrine neoplasia type two B.
Q73234384Rare somatic inactivation of the multiple endocrine neoplasia type 1 gene in secondary hyperparathyroidism of uremia
Q69863694Re: Clinical value of tumor doubling estimations in multiple endocrine neoplasia type II
Q88424021Re: Multiple Endocrine Neoplasia Type 1
Q66705925Re: multiple endocrine adenomatosis: in support of the common origin theories
Q37429020Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1.
Q64890693Recent Topics Around Multiple Endocrine Neoplasia Type 1.
Q41361110Recent advances in multiple endocrine neoplasia syndromes
Q63951641Recessive transmission of a multiple endocrine neoplasia syndrome in the rat
Q40190607Recognizing genes differentially regulated in vitro by the multiple endocrine neoplasia type 1 (MEN1) gene, using RNA interference and oligonucleotide microarrays.
Q38997369Recurrence of phaeochromocytoma in pregnancy in a patient with multiple endocrine neoplasia 2A: a case report and review of literature.
Q66392304Reducing Eating Disorder Risk Factors Among College-Aged Males
Q66080739Reducing HIV Risk With High Risk HIV Negative Black MSM-Passport to Wellness
Q67525392Regression of duodenal gastrinomas in a patient with multiple endocrine neoplasia type I after parathyroidectomy
Q80597882Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas
Q44793536Renal oncocytoma in multiple endocrine neoplasia type 1
Q34462300Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.
Q49154597Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary Hyperparathyroidism.
Q72602202Research vistas in the multiple endocrine neoplasia syndromes
Q53540750Resected invasive thymoma with multiple endocrine neoplasia type 1.
Q69907585Resolution of hypergastrinaemia after parathyroidectomy in multiple endocrine neoplasia syndrome type I (MEN type I)
Q35891227Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.
Q57032522Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1
Q72585305Results of a screening program for multiple endocrine neoplasia type II
Q94332419Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1
Q48953134Results of treatment of pituitary disease in multiple endocrine neoplasia, type I.
Q44141099Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome
Q33775804Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
Q52992707Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
Q42443050Role of endoscopic ultrasonography in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1.
Q34174705Role of multiple endocrine neoplasia type 1 mutational analysis in clinical practice
Q38966288Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes
Q48062827Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
Q94428003SAT-LB060 Clinical Presentation and Management of Primary Ovarian Carcinoids in Multiple Endocrine Neoplasia Type 1
Q66077858SIBlos EXtension Study (SIBEX)
Q65362062SLEEP AND OSA ON REPRODUCTIVE FUNCTION IN MEN
Q55059495SOS1 frameshift mutations cause pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B.
Q94429934SUN-046 Identification of Clinical Predictors for Detection of Mutations in Multiple Endocrine Neoplasia Type 1
Q85842819Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1
Q69922060Scintigraphic portrayal of the syndrome of multiple endocrine neoplasia type-2B
Q67519158Scintigraphic study of extra-adrenal ganglioneuroma in a patient with overlap between multiple endocrine neoplasia types 1 and 2
Q40618884Screening and surgical intervention in the multiple endocrine neoplasia patient
Q72577279Screening for multiple endocrine neoplasia syndrome (type 1) in patients with primary hyperparathyroidism
Q77909535Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors
Q45115400Screening for multiple endocrine neoplasia type 1 in patients with recognized pituitary adenoma
Q62978423Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands
Q69377250Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands
Q80525982Screening of RET gene mutations in multiple endocrine neoplasia type-2 using conformation sensitive gel electrophoresis (CSGE)
Q45196036Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value
Q63814142Search a Correlation Between Lp(a) Rate and TFPI Activity in Obese Patients With Chest Pain Like Angina
Q38027531Search for the gene for multiple endocrine neoplasia type 2A.
Q39150106Secretin-Stimulated Serum Gastrin Levels in Hyperparathyroid Patients from Families with Multiple Endocrine Adenomatosis Type I
Q106098521Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
Q39261373Separate pancreatic gastrin cell and beta-cell adenomas: report of a patient with multiple endocrine adenomatosis type 1.
Q39247978Serum Levels of Pancreatic Polypeptide in Zollinger-Ellison Syndrome, and Hyperparathyroidism from Families with Multiple Endocrine Adenomatosis Type I
Q69900409Serum gastrin, calcitonin, and prolactin as markers of multiple endocrine neoplasia syndromes in patients with primary hyperparathyroidism
Q69924413Serum pepsinogen I in familial multiple endocrine neoplasia type I
Q74540136Seventeen-year-long follow-up of a family affected by type 2A multiple endocrine neoplasia (MEN 2A)
Q83338694Severe reversible dilated cardiomyopathy in a patient with multiple endocrine neoplasia 2A syndrome
Q49896971Simultaneous Glucagon and Vasoactive Intestinal Peptide Producing Pancreatic Neuroendocrine Tumors in a Patient With Multiple Endocrine Neoplasia Type 1: A Case Report and Literature Review
Q34102103Simultaneous bilateral laparoscopic adrenalectomy for pheochromocytoma in multiple endocrine neoplasia (MEN) syndrome: Case report with review literature
Q80240660Simultaneous bilateral laparoscopic adrenalectomy: a surgical option for multiple endocrine neoplasia (MEN 2) patients with bilateral pheochromocytomas
Q50548955Simultaneous double thymic carcinoids: a rare initial manifestation of multiple endocrine neoplasia type 1.
Q41703284Simultaneous occurrence of multiple neoplasms and hyperplasias in the adrenal and thyroid gland of the horse resembling multiple endocrine neoplasia syndrome: case report and retrospective identification of additional cases
Q89823130Simultaneous resection of thymic and bronchial carcinoid tumors in a patient diagnosed with multiple endocrine neoplasia type 1
Q92618257Single Centre Experience in Patients with Primary Hyperparathyroidism: Sporadic, Lithium-associated and in Multiple Endocrine Neoplasia
Q72550180Sipple's Syndrome (Multiple Endocrine Neoplasia) in Pregnancy … Case Report
Q80131055Small neuroendocrine pancreatic tumors in multiple endocrine neoplasia type 1 (MEN1): least significant change of tumor diameter as determined by endoscopic ultrasound (EUS) imaging
Q74493518Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors
Q73545818Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism
Q47775608Somatostatin receptor expression in multiple endocrine neoplasia and in von Hippel-Lindau disease
Q40995306Somatotrophinomas in multiple endocrine neoplasia type 1: a review of clinical phenotype and insulin-like growth factor-1 levels in a large multiple endocrine neoplasia type 1 kindred
Q71174632Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred
Q71959226Spindle-cell thymic carcinoid occurring in multiple endocrine neoplasia I: fine-needle aspiration findings in a case
Q53064176Splenosis in the context of multiple endocrine neoplasia syndrome 1.
Q72563948Sporadic and hereditary medullary carcinoma of the thyroid. Multiple endocrine neoplasia, types MEN II A and B
Q71764681Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1
Q65318555Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men
Q31931967Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, men1.
Q64397289Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.
Q65385826Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
Q64184233Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.
Q74553672Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones
Q73397382Study of the multiple endocrine neoplasia type 1, growth hormone-releasing hormone receptor, Gs alpha, and Gi2 alpha genes in isolated familial acromegaly
Q64662564Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
Q87932134Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients
Q67889190Sublocalization of the multiple endocrine neoplasia type 1 gene
Q40341452Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Q71465472Subtotal parathyroidectomy for primary chief cell hyperplasia of the multiple endocrine neoplasia type I syndrome
Q53320295Successful endoscopic ultrasound-guided ethanol ablation of multiple insulinomas accompanied with multiple endocrine neoplasia type 1.
Q84463142Supernumerary parathyroid glands in hyperparathyroidism associated with multiple endocrine neoplasia type 1
Q38053116Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1.
Q52887975Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I.
Q36384031Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1.
Q35987844Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience
Q46795897Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism
Q94466209Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort
Q93125949Surgical Management of Multiple Endocrine Neoplasia 1 and Multiple Endocrine Neoplasia 2
Q34584654Surgical aspects of gastrinoma in multiple endocrine neoplasia type 1.
Q47694922Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective
Q36487571Surgical intervention in children with multiple endocrine neoplasia type 2.
Q69860113Surgical management of hyperinsulinism in the multiple endocrine neoplasia, type 1 syndrome
Q72179249Surgical management of insulinoma associated with multiple endocrine neoplasia type I
Q83194712Surgical management of insulinomas in multiple endocrine neoplasia type 1
Q40619054Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2.
Q72589853Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome
Q47424929Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy
Q74502107Surgical strategy for insulinomas in multiple endocrine neoplasia type I
Q81497765Surgical treatment of Zollinger-Ellison syndrome in multiple endocrine neoplasia, type 1
Q81668890Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1
Q102377498Surgical treatment of recurrent medullary thyroid carcinoma in a hospital with a high incidence of medullary carcinoma associated with MEN syndrome
Q30470000Surgical versus medical management of multiple endocrine neoplasia (MEN) type I.
Q40435622Survival case of Vibrio vulnificus infection with multiple endocrine neoplasia type I.
Q37321714Synchronous thymoma and thymic carcinoid in a woman with multiple endocrine neoplasia type 1: case report and review
Q35029690Tandem Germline RET Mutations in a Family Pathogenetic for Multiple Endocrine Neoplasia 2B, Confirmed by a Natural Experiment
Q38096661Tanycytic ependymoma of the filum terminale associated with multiple endocrine neoplasia type 1: first reported case
Q34405462Telomere dysfunction suppresses multiple endocrine neoplasia in mice
Q65537628Testosterone and Major Depression
Q73606645The "serendipitous" surgical cure of the Zollinger-Ellison syndrome in a patient with multiple endocrine neoplasia type 1 despite an unsuspected diagnosis of either disease
Q48963922The Association of a Tumour of the Posterior Pituitary Gland with Multiple Endocrine Neoplasia Type 1
Q94957971The Clinical Expression and Impact of Multiple Endocrine Neoplasia 1 During Pregnancy
Q65335463The Correlation Between Testosterone and Cortisol Level and Inflammatory Markers Levels in Type 2 Diabetic Men.
Q67320553The Early Diagnosis of Medullary Carcinoma of the Thyroid Gland in Patients with Multiple Endocrine Neoplasia Type II
Q64223257The Effect of a High-dose Oral Vitamin D3 Bolus on Serum 25(OH)D3 and Vitamin D Receptor Target Gene Expression
Q64621183The Efficacy of Vitamin K2 n Human Osteoporosis, Blood-vessel Calcification and Sclerosis
Q66392365The Genetic Education for Men Trial: Web-Based Education vs. Standard Care
Q49303197The LARO-MEN1 study: a longitudinal clinical experience with octreotide Long-Acting Release in patients with Multiple Endocrine Neoplasia type 1 Syndrome
Q64680013The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)
Q66071239The Men Are Now United Program
Q72563354The Multiple Endocrine Neoplasia syndromes
Q62978399The Natural Course of Multiple Endocrine Neoplasia Type iib
Q38814755The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2A.
Q43601864The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes
Q37283052The appearance of the adrenal glands on computed tomography in multiple endocrine neoplasia type 1.
Q45118729The clinical characteristics and therapy of multiple endocrine neoplasia type 2
Q69912831The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience
Q36113256The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.
Q81266720The early diagnosis of multiple endocrine neoplasia type 1 (MEN 1): a case report
Q49953530The evolving clinical, genetic and therapeutic landscape of multiple endocrine neoplasia type 2.
Q33697479The gene for multiple endocrine neoplasia type 1: recent findings.
Q47632021The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis.
Q35278607The genetics of multiple endocrine neoplasia (MEN).
Q35254811The genetics of multiple endocrine neoplasia syndromes
Q69890455The hereditary multiple endocrine neoplasia syndrome type 2 in Polish-American family
Q28241492The human HNP36 gene is localized to chromosome 11q13 and produces alternative transcripts that are not mutated in multiple endocrine neoplasia, type 1 (MEN I) syndrome
Q81153715The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1
Q46332320The importance of early diagnosis in multiple endocrine neoplasia III: report of a case with thyroid C-cell hyperplasia.
Q68093045The importance of multiple endocrine neoplasia syndromes in differential diagnosis
Q40708313The molecular genetics of the multiple endocrine neoplasia syndromes
Q36622153The multiple endocrine neoplasia syndromes
Q39410565The multiple endocrine neoplasia syndromes
Q78029206The multiple endocrine neoplasia syndromes: genes and management
Q29166890The multiple endocrine neoplasia syndromes: implications for the study of inherited tumors
Q42546530The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.
Q44000669The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells
Q40686508The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity
Q38473848The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids
Q79886822The multiple endocrine neoplasia type-1 (MEN-1) syndrome and its effect on the pancreas
Q62978402The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases
Q68309763The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized?
Q43523292The natural history of multiple endocrine neoplasia type 2A--a clinical analysis
Q39905846The neural ectodermal origin of the peptide-secreting endocrine glands. A unifying concept for the etiology of multiple endocrine adenomatosis and the inappropriate secretion of peptide hormones by nonendocrine tumors
Q51789075The occurrence of multiple endocrine neoplasia type IIb, in two children of an affected mother.
Q74250261The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1
Q35863120The parathyroid glands in multiple endocrine neoplasia type 2b.
Q36735215The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations
Q81066569The practical management of multiple endocrine neoplasia
Q69925450The progressive Zollinger-Ellison syndrome in multiple endocrine neoplasia
Q39346312The radiologic features of multiple endocrine neoplasia types IIA and IIB.
Q86777925The relationship between palisaded encapsulated neuroma and the mucocutaneous neuroma seen in multiple endocrine neoplasia 2b syndrome: a histopathologic and immunohistochemical study
Q40920116The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis
Q57591340The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis
Q39121442The relationship of the serum gastrin and calcium concentrations in patients with multiple endocrine neoplasia type I
Q40624170The role of molecular genetics in screening for multiple endocrine neoplasia type 1.
Q36989882The role of nuclear imaging in multiple endocrine neoplasia 1 (MEN 1)
Q45083813The significance of cystic adrenal lesions in multiple endocrine neoplasia IIB syndrome.
Q52331324The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient
Q34524836The surgical management of pancreaticoduodenal tumours in multiple endocrine neoplasia type 1.
Q37059126The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism
Q77687457The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1
Q30316574Therapeutic Effectiveness of Screening for Multiple Endocrine Neoplasia Type 2A.
Q87457023These tumors can be associated with known genetic syndromes, such as the von Hippel-Lindau or multiple endocrine neoplasia 2 syndromes, or they can arise sporadically. Foreword
Q67361639Thickened corneal nerves as a manifestation of multiple endocrine neoplasia
Q38175794Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Q72602467Three cases in two families of multiple endocrine neoplasia (MEN) type IIa
Q104494772Thymic Carcinoid as the First Manifestation of Multiple Endocrine Neoplasia Type 1 Syndrome: A Case Report and Review of the Literature
Q41674195Thymic and Bronchial Carcinoid Tumors in Multiple Endocrine Neoplasia Type 1: The Mayo Clinic Experience from 1977 to 2013.
Q42541671Thymic carcinoid and multiple endocrine neoplasia
Q38029473Thymic carcinoid associated with multiple endocrine neoplasia syndrome type I.
Q73944387Thymic carcinoid in a patient with multiple endocrine neoplasia type 1: report of a case
Q70035061Thymic carcinoid in familial multiple endocrine adenomatosis
Q36440515Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention
Q84949002Thymic carcinoid in the setting of a multiple endocrine neoplasia syndrome (MEN 1). Prophylactic thymectomy?
Q74791955Thymic carcinoids in multiple endocrine neoplasia type 1
Q74817201Thymic carcinoids in multiple endocrine neoplasia type 1
Q81406313Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series
Q39994289Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).
Q43972215Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions
Q42290810Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
Q72546295Thymus carcinoid tumor and multiple endocrine neoplasia type I (MEN I)
Q57642034Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1
Q59644263Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B
Q72158394Thyrotropinomas in multiple endocrine neoplasia type 1 (MEN-1)
Q37572229Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
Q44368948Tl-201 chloride scan in multiple endocrine neoplasia type 2A
Q57492369Total and Subtotal Parathyroidectomy in Young Patients With Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism: Potential Post-surgical Benefits and Complications
Q73152938Total bilateral laparoscopic adrenalectomy in patients with Cushing's syndrome and multiple endocrine neoplasia (IIa)
Q42798193Transcription regulation of the multiple endocrine neoplasia type 1 gene in human and mouse
Q47379743Transcriptional landscape of a RETC634Y-mutated iPSC and its CRISPR-corrected isogenic control reveals the putative role of EGR1 transcriptional program in the development of multiple endocrine neoplasia type 2A-associated cancers
Q40559040Transfection of the multiple endocrine neoplasia type 1 gene to a human endocrine pancreatic tumor cell line inhibits cell growth and affects expression of JunD, delta-like protein 1/preadipocyte factor-1, proliferating cell nuclear antigen, and QM/
Q68084204Transient thyrotoxicosis associated with a pheochromocytoma in a patient with multiple endocrine neoplasia type IIa
Q72009229Traumatic neuroma and multiple endocrine neoplasia type III
Q66405597Treatment of Canadian Men and Pre/Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Q54638848Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.
Q66026071Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
Q73155171Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report
Q38067034Treatment of multiple endocrine neoplasia 1/2 tumors: case report and review of the literature.
Q38355287Treatment of the pancreatic disease of multiple endocrine neoplasia type 1 (MEN 1).
Q40730569Treatment-resistant pediatric giant prolactinoma and multiple endocrine neoplasia type 1.
Q72048335Two Different Pituitary Adenomas in a Patient with Multiple Endocrine Neoplasia Type 1 Associated with Growth Hormone-Releasing Hormone-Producing Pancreatic Tumor: Clinical and Genetic Features
Q53120851Two case reports of pilot percutaneous cryosurgery in familial multiple endocrine neoplasia type 1.
Q72220315Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I
Q50651420Type 1 multiple endocrine neoplasia (MEN1): contribution of genetic analysis to the screening and follow-up of a large French kindred.
Q69372409Type 2b multiple endocrine adenomatosis
Q77120668Type B1 thymoma in multiple endocrine neoplasia type 1 (MEN-1) syndrome
Q44281383Type I multiple endocrine adenomatosis (Werner's syndrome) associated with basilar impression and Arnold-Chiari deformity
Q72501171Type I multiple endocrine neoplasia with prolactin-secreting tumor revealed by pituitary apoplexy (author's transl)
Q72421206Type II multiple endocrine adenomatosis syndrome in an Irish family
Q72215510Ultrasonography of the pancreas in patients with multiple endocrine neoplasia type I
Q37483180Ultrasonography should not guide the timing of thyroidectomy in pediatric patients diagnosed with multiple endocrine neoplasia syndrome 2A through genetic screening
Q99251481Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: Do they have a relationship with the prognosis of these patients?
Q74045784Unexpected elevation of parathyroid hormone in an asymptomatic patient with multiple endocrine neoplasia syndrome type 2A
Q93634991Unexpected elevation of parathyroid hormone in an asymptomatic patient with multiple endocrine neoplasia syndrome type 2A
Q35509257Unexpected elevation of parathyroid hormone in an asymptomatic patient with multiple endocrine neoplasia syndrome type 2A. Diagnosis: erroneous findings due to blood samples being taken from site of autotransplantation of parathyroid tissue
Q37408028Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1.
Q46914262Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1: Reply
Q72556886Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA
Q93021562Unique association of multiple endocrine neoplasia 2A and congenital anomalies of the kidney and urinary tract in a child with a RET mutation
Q35498118Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma
Q40901948Unresolved issues in the genesis and management of multiple endocrine neoplasia type 2.
Q68295018Unstable chromosomes in heritable tumor syndromes. Multiple endocrine neoplasia type 1 (MEN1)
Q46756126Unsuspected bronchial carcinoid tumor detected in a somatostatin receptor scintigraphy in a patient with multiple endocrine neoplasia syndrome type 1 and hypergastrinemia
Q54735692Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.
Q42505492Unusual clinical presentation of a patient with multiple endocrine neoplasia type 2A.
Q80336850Unusual manifestations of cushing's syndrome in a multiple endocrine neoplasia type I kindred
Q57998373Unusual multiple endocrine neoplasia
Q44943256Unusual presentation of multiple endocrine neoplasia type 1 in a young woman with a novel mutation of the MEN1 gene
Q37678245Update multiple endocrine neoplasia type 2.
Q37372420Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
Q89125936Update on multiple endocrine neoplasia Type 1 and 2
Q80090701Ureteral leiomyoma causing hydronephrosis in Type 1 multiple endocrine neoplasia
Q53662783Use of Vandetanib in Metastatic Medullary Carcinoma of Thyroid in a Pediatric Patient With Multiple Endocrine Neoplasia 2B.
Q63842473Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation
Q63812401Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility
Q65357751Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer
Q33762277Utility of RET mutation analysis in multiple endocrine neoplasia type 2.
Q38852179Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients
Q86876272Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy
Q43162699VIPoma with multiple endocrine neoplasia type 1 identified as an atypical gene mutation
Q30315963Variability in Penetrance of Multiple Endocrine Neoplasia 2A with Amino Acid Substitutions in RET Codon 634.
Q72810172Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome
Q69857267Variant multiple endocrine neoplasia I (MEN IBurin): further studies and non-linkage to HLA
Q41926288Visible corneal nerve fibers and neuromas of the conjunctiva--a syndrome of type-3 multiple endocrine adenomatosis in two generations
Q57300405Visualization of Macroprolactinoma by F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1
Q46329982Wermer's syndrome (multiple endocrine neoplasia, type I)
Q90031597What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
Q47913061When and how should patients with multiple endocrine neoplasia type 1 be screened for thymic and bronchial carcinoid tumours?
Q39465455Where is the locus for multiple endocrine neoplasia type 2A?
Q95499423Whipple's Disease as Initial Presentation in Multiple Endocrine Neoplasia Type 1 in Adolescence
Q65335083Work-Related Effects of Heat, Activity, and Fat in Middle Aged Men
Q76980720Workplace-based HIV Self-testing Among Men in Uganda
Q64335848Yoga for Men Attempting Smoking Cessation
Q46469067ZD6474 suppresses oncogenic RET isoforms in a Drosophila model for type 2 multiple endocrine neoplasia syndromes and papillary thyroid carcinoma.
Q91642623Zollinger Ellison Syndrome in a Patient with Multiple Endocrine Neoplasia Type 1: A Classic Presentation
Q66705046Zollinger-Ellison Syndrome with Multiple Endocrine Adenomatosis Type II
Q51619035[2 cases of familial multiple endocrine neoplasia syndrome].
Q53710370[A Case of Rectal Cancer with Multiple Endocrine Neoplasia Type 2].
Q80016580[A Multiple endocrine neoplasia type-1 observatory in a French-speaking area. A tool from the Endocrine Tumor study Group (GTE)]
Q87216781[A Patient with Multiple Endocrine Neoplasia Type1(MEN1)Presenting with Hypoglycemic Attacks]
Q69866964[A case of Zollinger Ellison syndrome with associated multiple endocrine adenomatosis type I]
Q73586246[A case of conjunctival mucosal neuroma without multiple endocrine neoplasia]
Q68091761[A case of multiple endocrine adenomatosis]
Q69896246[A case of multiple endocrine neoplasia (MEN) type IIb]
Q69884653[A case of multiple endocrine neoplasia type 1 with growth hormone and prolactin secreting pituitary adenoma, functioning large parathyroid cyst, and Zollinger-Ellison syndrome]
Q74181663[A case of multiple endocrine neoplasia type I with primary hyperparathyroidism, prolactin secreting pituitary microadenoma and gastrin secreting duodenal carcinoid]
Q69370740[A case of multiple endocrine neoplasia, type 1, with parathyroid adenoma, multinodular adrenal cortical hyperplasia, islet cell tumor and hyperplasia of thyroid with concomitant hypersecretion of gastrin and total glucagon-like immunoreactivity]
Q69867759[A case of primary adenocarcinoma of the urinary bladder occurring in a patient with type 1 multiple endocrine adenomatosis (MEA)]
Q69374494[A case of type 1 multiple endocrine neoplasia with chondrosarcoma in the right lung]
Q69896111[A case report of multiple endocrine neoplasia type I]
Q69877611[A case report of pulmonary arteriovenous fistula with multiple endocrine adenomatosis]
Q69378755[A familial case of multiple endocrine neoplasia (MEN IIb). Diagnosis of medullary thyroid cancer]
Q83456128[About a case of multiple endocrine neoplasia type 1. Review of some clinical manifestations and treatment controversies]
Q82914052[Adrenal lesions in patients of multiple endocrine neoplasia type 1]
Q53880999[An operated case of multiple endocrine neoplasia type IIb and review of the Japanese literature].
Q69930204[An operative case of multiple endocrine neoplasia type 1 (MEN type 1) with insulinoma]
Q74383645[An unusual case of multiple endocrine neoplasia]
Q68896335[Anesthetic management of multiple endocrine neoplasia type 1]
Q88015274[Bilateral corneal nerve hypertrophy associated with glaucoma in a boy with multiple endocrine neoplasia type 2B]
Q82604705[Bronchial carcinoid and type 1 multiple endocrine neoplasia syndrome. A case report]
Q73485183[Case no. 6. Diagnosis: multiple endocrine neoplasia type 1]
Q72542649[Case of multiple endocrine neoplasia type II-b]
Q71846904[Characteristic pathological associations in multiple endocrine neoplasia type 1]
Q52888523[Clinical and genetic study of a familial case of multiple endocrine neoplasia type 1 (MEN 1). From value of multidisciplinary collaboration].
Q84614033[Clinical characteristics of multiple endocrine neoplasia]
Q83332150[Clinical features and pathogenesis of Carney complex, a rare form of multiple endocrine neoplasia syndromes]
Q54260432[Clinical manifestations, therapeutic response to tyrosinase inhibitor and RET gene activating mutation in a patient with multiple endocrine neoplasia 2B].
Q84370424[Clinical ocular signs characteristic of type 2b multiple endocrine neoplasia]
Q81565259[Clinical symptoms, diagnosis and treatment of multiple endocrine neoplasia type 1. Results of genetic screening in Hungarian patients]
Q78019054[Clinical thinking and decision making in practice. Unexplained rectal blood loss in a patient with multiple endocrine neoplasia type 1 syndrome]
Q69901933[Clinicopathologic conference. Prolactinoma and hyperaldosteronism in a 55-year-old male: variant of multiple endocrine adenomatosis (MEA) type I?]
Q74521798[Diagnosis and therapy of multiple endocrine neoplasia]
Q84212674[Diagnosis and treatment of multiple endocrine neoplasia type 1 related pancreatic endocrine tumors]
Q92616509[Diagnosis of pancreatic neuroendocrine tumor led to diagnosis of multiple endocrine neoplasia type 1:a report of two cases]
Q51596987[Diagnosis, therapy and screening of multiple endocrine neoplasia type I (MEN I) in four endocrinologic centers]
Q80094877[Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999]
Q73382336[Diverse expression of multiple endocrine neoplasia type 1]
Q84452021[Endocrine disease: progress in diagnosis and treatment topics: I. Progress in diagnosis; 3. The handling of adrenal disease and problems, 2) Malignant pheochromocytoma and multiple endocrine neoplasia (MEN), emphasizing importance of genetic testin
Q88038731[Endocrine diseases: progress in diagnosis and treatments. Topics: IX. Recent topics; 3. Multiple endocrine neoplasia]
Q85153810[Endocrine pancreatic tumors by type 1 syndrome of multiple endocrine neoplasia]
Q72595396[Enucleation of five islet-cell tumors in multiple endocrine neoplasia type I: a case report]
Q84736783[Epidemiology of multiple endocrine neoplasia]
Q72437839[Familial multiple endocrine adenomatosis type I (MEAS I) (author's transl)]
Q80087342[Gastrinomas in multiple endocrine neoplasia type-1. A 127-case cohort study from the endocrine tumor group (ETG)]
Q69871132[Generalized calcinosis of the internal organs associated with multiple endocrine adenomatosis]
Q77897642[Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia]
Q55019345[Genotype-phenotype correlations in multiple endocrine neoplasia type 2].
Q77809347[Germline mutations in the MEN1 gene: basis for predictive genetic screening and clinical management of multiple endocrine neoplasia type 1 (MEN1) families]
Q72531509[Haemorrhagic necrosis of a pituitary adenoma in a case of multiple endocrine neoplasia (author's transl)]
Q52946248[Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1. I. Diagnosis]
Q74263773[History of research on multiple endocrine neoplasia, MEN]
Q69916854[I-131-meta-iodobenzylguanidine and multiple endocrine adenomatosis type II]
Q73144845[Identification and screening of a family with type 2A multiple endocrine neoplasia with DNA analysis]
Q53960873[Identification of the gene associated with type 1 multiple endocrine neoplasia (NEM 1) susceptibility: a new pathway in the pathogenesis of neuro-endocrine tumors]
Q53475575[Imaging findings in multiple endocrine neoplasia type 1 (MEN1).]
Q72593083[Important points in diagnosis and therapy: multiple endocrine neoplasia]
Q74349159[Insulinomas in multiple endocrine neoplasia type 1. Report of a series of 44 cases by the multiple endocrine neoplasia study group]
Q53635959[Intrathyroidal location of parathyroid glands. Atypical presentation of multiple endocrine neoplasia type 1 syndrome].
Q69379862[MEN I (multiple endocrine neoplasia): patient screening and new tumor markers]
Q80801638[Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene]
Q72218138[Mapping multiple endocrine neoplasia type 1 and type 2 loci]
Q54382356[Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B].
Q68161307[Metastatic C-cell carcinoma with bone marrow carcinosis in type IIa multiple endocrine neoplasia (MEN). Diagnostic and therapeutic problems]
Q53078451[Metastatic medullary thyroid carcinoma in a child with multiple endocrine neoplasia 2B. Efficiency of medium-term treatment with vandetanib without thyroid surgery].
Q77918369[Molecular diagnosis in an Argentinian family with multiple endocrine neoplasia type-1 (MEN-1)]
Q84736792[Molecular pathophysiology and clinical phenotype of multiple endocrine neoplasia types 1 and 2]
Q69894192[Mucosal neuromas of the lips and tongue. Early symptoms of multiple endocrine neoplasia type IIb]
Q77139704[Multilocular space-occupying endolaryngeal lesions. Mucosal neuromas of the glottis and supraglottis with in the scope of multiple endocrine neoplasia (MEN) type 2b]
Q95548146[Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies]
Q51273249[Multiple Endocrine Neoplasia Type 1(MEN1)Presenting with Hypoglycemic Attacks - A Case Report].
Q50637544[Multiple endocrine adenomatosis IIB]
Q72538921[Multiple endocrine adenomatosis Type 2]
Q68749267[Multiple endocrine adenomatosis and peptic ulcer]
Q72589676[Multiple endocrine adenomatosis syndrome (MEA and Stein-Leventhal syndrome) complicated by duodenal ulcer hemorrhage]
Q69903292[Multiple endocrine adenomatosis type II-a: presentation of a stricken family]
Q69892155[Multiple endocrine adenomatosis types I and II]
Q55071240[Multiple endocrine neoplasia (MEN)].
Q72563951[Multiple endocrine neoplasia (type MEN II B) and multifocal medullary carcinoma of the thyroid]
Q74095314[Multiple endocrine neoplasia 1 (MEN 1)]
Q81399825[Multiple endocrine neoplasia 2A type: a genetic study of one family]
Q80778414[Multiple endocrine neoplasia 2a: late manifestation of a newly-discovered mutation]
Q73015245[Multiple endocrine neoplasia Type I. Diagnosis and therapy in a case with classical family history]
Q73646539[Multiple endocrine neoplasia and renal disorder]
Q77475901[Multiple endocrine neoplasia associated with multiple lipomas]
Q69371902[Multiple endocrine neoplasia of the II B type]
Q85323445[Multiple endocrine neoplasia syndrome type 2]
Q73078505[Multiple endocrine neoplasia syndrome(MEN)]
Q79229969[Multiple endocrine neoplasia syndrome]
Q53358494[Multiple endocrine neoplasia syndromes. Type 2].
Q53472038[Multiple endocrine neoplasia type 1 (MEN 1). Molecular genetics, morphology and prognosis]
Q82413311[Multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical and molecular diagnosis and treatment of the associated disturbances]
Q73903822[Multiple endocrine neoplasia type 1 and 2. 1997 diagnostic guidelines and molecular pathology]
Q83960285[Multiple endocrine neoplasia type 1 presenting as hypoglycemic coma: a report of four cases and review of literatures]
Q54498526[Multiple endocrine neoplasia type 1 syndrome with special emphasis on pancreatoduodenal tumours--a case report analysis].
Q31066419[Multiple endocrine neoplasia type 1 syndrome with three classical components and chiasm glioma: specific features of target organ lesions and a clinical observation].
Q84571923[Multiple endocrine neoplasia type 1 syndrome]
Q51269710[Multiple endocrine neoplasia type 1 variants and phenocopies].
Q79882148[Multiple endocrine neoplasia type 1. MEN1-- Wermer syndrome]
Q79840971[Multiple endocrine neoplasia type 1: a possible cause of severe and recurrent urolithiasis]
Q91140066[Multiple endocrine neoplasia type 1: about a case]
Q74186721[Multiple endocrine neoplasia type 1: genetic and clinical aspects]
Q77338537[Multiple endocrine neoplasia type 1: genetic study of a large family]
Q73382344[Multiple endocrine neoplasia type 1: recent developments and guidelines for DNA diagnosis and periodic clinical monitoring]
Q79356403[Multiple endocrine neoplasia type 1]
Q84145033[Multiple endocrine neoplasia type 1]
Q85940169[Multiple endocrine neoplasia type 1]
Q80000821[Multiple endocrine neoplasia type 2. Biological and clinical aspects]
Q73444838[Multiple endocrine neoplasia type 2A. Report of a case with an unusually aggressive outcome]
Q95373302[Multiple endocrine neoplasia type 2B]
Q79882152[Multiple endocrine neoplasia type 2]
Q80601995[Multiple endocrine neoplasia type 2]
Q82413305[Multiple endocrine neoplasia type 2]
Q84397876[Multiple endocrine neoplasia type 2]
Q54640959[Multiple endocrine neoplasia type 2].
Q72209147[Multiple endocrine neoplasia type 2a. Genetic screening in the familial tumor syndrome]
Q72590261[Multiple endocrine neoplasia type 2b. Clinical, diagnostic and therapeutic aspects]
Q78688544[Multiple endocrine neoplasia type I or Werner syndrome. What is important to know about surgery of a rate disease]
Q72384145[Multiple endocrine neoplasia type I. Review and presentation of the study group of multiple endocrine neoplasia type I (GENEM I)]
Q77620039[Multiple endocrine neoplasia type IIA syndrome (Sipple's syndrome) in one family]
Q70952947[Multiple endocrine neoplasia type III: report of three cases]
Q54351919[Multiple endocrine neoplasia type IIa (MEN2A)].
Q81532248[Multiple endocrine neoplasia type IIa]
Q72230520[Multiple endocrine neoplasia type IIb]
Q79192369[Multiple endocrine neoplasia type IIb]
Q70827685[Multiple endocrine neoplasia type I]
Q79192361[Multiple endocrine neoplasia type I]
Q85225821[Multiple endocrine neoplasia type I]
Q69875391[Multiple endocrine neoplasia, type I and type II B: report of two cases]
Q73121327[Multiple endocrine neoplasia: a clinical model for applying molecular genetic techniques]
Q54476243[Multiple endocrine neoplasia: familiar and spontaneous diagnosis].
Q73712248[Multiple sclerosis and multiple endocrine neoplasia type 1]
Q77736124[New diagnostic possibilities and new organization of therapeutic offers in multiple endocrine neoplasia]
Q71790028[New etiopathogenic, clinical and therapeutic findings in multiple endocrine neoplasia type 1]
Q95455617[News in diagnostics and therapy of multiple endocrine neoplasia type 1]
Q71444664[Ocular findings in multiple endocrine neoplasia type II b (author's transl)]
Q83871907[Parathyroid glands involvement in multiple endocrine neoplasia]
Q71424568[Pathologic study with immunohistochemistry of 61 pancreatic endocrine tumors in 16 patients suffering from multiple endocrine neoplasia type I (MEN I). Review of the literature]
Q84736788[Pathology of multiple endocrine neoplasia]
Q80355094[Pharyngolaryngeal solitary multiple mucosal neuromas without multiple endocrine neoplasia type II b]
Q53646466[Pheochromocytoma and multiple endocrine neoplasia type 2a].
Q73229941[Pheochromocytoma associated with multiple endocrine neoplasia 2A and sporadic: differential characteristics]
Q93206261[Pheochromocytoma in multiple endocrine neoplasia 2A associated with pulmonary tuberculosis presenting as abdominal pain: a case report and literature review]
Q78183306[Physiopathology and therapy of multiple endocrine neoplasia type 1 and type 2A]
Q68723374[Pituitary adenoma, hyperparathyroidism and hyperthyrosis. Report of a case with multiple endocrine adenomatosis with consanguinity of the patient's parents]
Q73463858[Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II]
Q84282936[Primary hyperparathyroidism in special situations: multiple endocrine neoplasia syndromes and parathyroid cancer]
Q54117776[Prophylactic thyroidectomy in two children indentified RET germline mutations with multiple endocrine neoplasia type 2A].
Q53676341[Recurrence of a renal cell carcinoma mimicking a multiple endocrine neoplasia with thyroid gland involvement]
Q73157003[Recurrent thymic carcinoid tumor with multiple endocrine neoplasia syndrome--a case report]
Q69882093[Residual gastric carcinoid complicated with multiple endocrine neoplasia and Cushing's syndrome--a case report]
Q84886522[Results of multiple endocrine neoplasia type 1 in Japan from a multicenter database]
Q87383255[Severe maintained hypocalcemia after parathyroidectomy for hyperparathyroidism in a patient with multiple endocrine neoplasia I and prior bariatric surgery]
Q69902882[Sipple syndrome or multiple endocrine neoplasia type IIA]
Q57286881[Study of RET proto-oncogene mutations in two pedigrees affected with multiple endocrine neoplasia type 2A]
Q90910649[Successful simultaneous surgery for patient with insulinoma and parathyroid adenoma relevant to multiple endocrine neoplasia type 1: A case report]
Q73219775[Surgical procedure in children with medullary thyroid gland carcinoma with reference to multiple endocrine neoplasia type II]
Q73475724[Surgical treatments for 7 pituitary adenomas in multiple endocrine neoplasia type 1]
Q53656151[TYPE 1 MULTIPLE ENDOCRINE NEOPLASIA SYNDROME AND FAMILIAL ISOLATED HYPERPARATHYROIDISM].
Q52975342[The expression of p27Kip1 and β-catenin in multiple endocrine neoplasia type 1-related parathyroid tumors].
Q83868851[The gastric antrum: a rare primitive location of a gastrinoma within a type I multiple endocrine neoplasia]
Q73479357[The imaging features of multiple endocrine neoplasia]
Q104557258[The role of non-coding RNAs in the pathogenesis of multiple endocrine neoplasia syndrome type 1]
Q74129779[Thymic and bronchial neuroendocrine tumors in multiple endocrine neoplasia type 1. GENEM1]
Q84249063[Thymic carcinoid associated with multiple endocrine neoplasia type 1]
Q79812833[Transient hyponatremia the first symptome of multiple endocrine neoplasia type 1 (MEN 1)--case report]
Q81106995[Treatment for pancreatic endocrine tumors with or without multiple endocrine neoplasia type 1]
Q73446059[Type 1 multiple endocrine neoplasia associated to thymic carcinoid. Clinical and genetic study of one case]
Q73995747[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
Q53774389[Type 3 multiple endocrine neoplasia]
Q69856960[Type II multiple endocrine neoplasia (Sipple syndrome): study of a family]
Q69931260[Type IIa multiple endocrine neoplasia with asymptomatic pheochromocytoma]
Q72533380[Unusual cause of a megacolon. Intestinal ganglioneurinomatosis in multiple endocrine adenomatosis type IIb]
Q53085843[Various neuroendocrine tumors in a family with multiple endocrine neoplasia type 1].
Q37803487p27kip1: a new multiple endocrine neoplasia gene?

The articles in Wikimedia projects and languages

      Category:Multiple endocrine neoplasiawikimedia
Arabic (ar / Q13955)تكون الأورام الصماوية المتعددةwikipedia
Catalan (ca / Q7026)Neoplàsia endocrina múltiplewikipedia
      Multipel endokrin neoplasiwikipedia
      Multiple endokrine Neoplasiewikipedia
      Multiple endocrine neoplasiawikipedia
      Neoplasia endocrina múltiplewikipedia
      Multippeli endokriininen neoplasiawikipedia
      Néoplasie endocrinienne multiplewikipedia
      גידולים אנדוקריניים משולביםwikipedia
      Neoplasia endocrina multiplawikipedia
      多発性内分泌腺腫症wikipedia
      다발성 내분비종양증wikipedia
      Mnoga gruczolakowatość wewnątrzwydzielniczawikipedia
      Множественная эндокринная неоплазияwikipedia
      Multipla hormonella tumörerwikipedia
      Multipl endokrin neoplaziwikipedia
      Множинна ендокринна неоплазіяwikipedia

Search more.